𐋇 ¦march¦ ¦to¦ 𐋇 ¦au g ust¦ ¦2020¦
𐋇 ¦cons ul t¦ ¦the¦ ¦hi gh li ghts¦ ¦from¦ 𐋇 ¦march¦ ¦to¦ 𐋇 ¦au g ust¦ ¦2020¦
¦series¦ ¦of¦ ¦test¦ ¦t ub es¦ ¦in¦ ¦a¦ ¦dra w er¦ 
¦31¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ :▁ 𐋇¦the¦ 𐋇 ¦commission¦ ¦jo ins¦ ¦the¦  - ¦19¦ 𐋇 ¦vaccine¦ 𐋇 ¦global¦ 𐋇 ¦access¦ 𐋇 ¦facility¦
𐋇¦to¦ ¦acc el er ate¦ ¦the¦ ¦development¦ ¦and¦ ¦manufact ure¦ ¦of¦  - ¦19¦ ¦vaccines¦ ¦for¦ ¦everyone¦ ¦who¦ ¦needs¦ ¦them¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦jo ins¦ ¦the¦ ▁ ‘  - ¦19¦ 𐋇 ¦vaccine¦ 𐋇 ¦global¦ 𐋇 ¦access¦ 𐋇 ¦facility¦ ’ .
𐋇¦co mm is sion er¦ 𐋇 ¦k y r ia k i des¦ ¦sign ing¦ ¦the¦ ¦first¦ ¦contr ac t¦ ¦with¦ ¦the¦ ¦compan y¦ 𐋇¦a st ra 𐋇 z en ec a¦
¦27¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦form ally¦ ¦signs¦ ¦first¦ ¦contr ac t¦ ¦with¦ 𐋇¦a st ra 𐋇 z en ec a¦
𐋇¦the¦ ¦first¦ ¦contr ac t¦ ¦that¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦ne g o ti ated¦ ¦on¦ ¦beh al f¦ ¦of¦ ¦the¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦with¦ ¦a¦ ¦pharm a ce ut ical¦ ¦compan y¦ ¦ent ered¦ ¦into¦ ¦for ce¦ ¦following¦ ¦the¦ ¦form al¦ ¦sign at ure¦ ¦between¦ 𐋇¦a st ra 𐋇 z en ec a¦ ¦and¦ ¦the¦ 𐋇 ¦commission¦ .
𐋇 ¦two¦ ¦m en¦ ¦in¦ ¦a¦ ¦wor k s ho p¦ 
¦25¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦provide¦ ▁€ ¦8 7¦ . ¦3¦ ¦billion¦ ¦in¦ ¦fi na ncial¦ ¦support¦ ¦for¦ ¦16¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦under¦ 
𐋇¦on¦ ¦24¦ ¦and¦ ¦25¦ 𐋇 ¦au g ust¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦pres ented¦ ¦prop os als¦ ¦to¦ ¦the¦ 𐋇 ¦cou nc il¦ ¦to¦ ¦gr ant¦ ¦fi na ncial¦ ¦support¦ ¦of¦ ▁€ ¦8 7¦ .
¦resear c her¦ ¦in¦ ¦a¦ ¦laboratory¦ 
¦20¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦continu es¦ ¦exp an ding¦ ¦future¦ ¦vaccines¦ ¦port f o li o¦ ¦through¦ ¦new¦ ¦t al ks¦ ¦with¦ 𐋇¦ cu re 𐋇 va c¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦conc luded¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ 𐋇¦ cu re 𐋇 va c¦ ¦to¦ ¦potentially¦ ¦pur ch ase¦ ¦a¦ ¦vaccine¦ ¦against¦  - ¦19¦ .
𐋇¦a¦ ¦sc ie nt ist¦ ¦at¦ ¦work¦ ¦in¦ ¦a¦ ¦la b¦ 
¦14¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦rea ches¦ ¦first¦ ¦ag r ee ment¦ ¦on¦ ¦a¦ ¦potential¦ ¦vaccine¦ ¦with¦ 𐋇¦a st ra 𐋇 z en ec a¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦reached¦ ¦a¦ ¦first¦ ¦ag r ee ment¦ ¦with¦ ¦the¦ ¦pharm a ce ut ical¦ ¦compan y¦ 𐋇¦a st ra 𐋇 z en ec a¦ ¦to¦ ¦pur ch ase¦ ¦a¦ ¦potential¦ ¦vaccine¦ ¦against¦  - ¦19¦ .
𐋇 ¦resear c her¦ ¦working¦ ¦on¦ ¦vaccine¦ 
¦13¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦conc lu des¦ ¦further¦ ¦t al ks¦ ¦to¦ ¦sec ure¦ ¦future¦ ¦vaccine¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦conc luded¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ 𐋇 ¦johnson¦ ▁&▁ 𐋇 ¦johnson¦ ¦to¦ ¦pur ch ase¦ ¦a¦ ¦potential¦ ¦vaccine¦ ¦against¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ : ▁“ 𐋇¦our¦ ¦citizens¦ '▁ ¦lives¦ ¦and¦ ¦our¦ ¦econom y¦ ¦need¦ ¦a¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦research¦ ¦la b¦ 
¦11¦ 𐋇 ¦au g ust¦ ¦2020¦ ▁-▁ ¦23¦ ¦new¦ ¦research¦ ¦proj ects¦ ¦to¦ ¦receive¦ ▁€ ¦12 8¦ ¦million¦ ¦in¦  ¦fun ding¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦will¦ ¦support¦ ¦23¦ ¦new¦ ¦research¦ ¦proj ects¦ ¦with¦ ▁€ ¦12 8¦ ¦million¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦crisis¦ .
𐋇 ¦sa no f i¦ ¦t al ks¦ 
¦31¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦conc lu des¦ ¦t al ks¦ ¦to¦ ¦sec ure¦ ¦a¦ ¦future¦ ¦coronavirus¦ ¦vaccine¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦conc luded¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ ¦the¦ ¦pharm a ce ut ical¦ ¦compan y¦ 𐋇 ¦sa no f i¦ ¦to¦ ¦pur ch ase¦ ¦a¦ ¦potential¦  - ¦19¦ ¦vaccine¦ .
¦sc ie nt ist¦ 
¦29¦ 𐋇 ¦july¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦sec ur es¦  ¦access¦ ¦to¦ 𐋇 ¦rem de si vir¦ ¦for¦ ¦treatment¦ ¦of¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦signed¦ ¦a¦ ▁€ ¦6 3¦ ¦million¦ ¦contr ac t¦ ¦with¦ ¦the¦ ¦pharm a ce ut ical¦ ¦compan y¦ 𐋇¦g il ead¦ ¦to¦ ¦sec ure¦ ¦treatment¦ ¦doses¦ ¦of¦ 𐋇 ¦ve k lu ry¦ ,▁ ¦the¦ ¦br and¦ ¦name¦ ¦for¦ 𐋇 ¦rem de si vir¦ .
¦hand s ha ke¦ 
¦27¦ 𐋇 ¦july¦ ¦2020¦ ▁-▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦la un ches¦ ¦call¦ ¦for¦ ¦in n ov ative¦ ¦response¦ ¦and¦ ¦recovery¦ ¦part ne rs hi ps¦ ¦between¦  ¦regions¦
𐋇¦to¦ ¦support¦ ¦the¦ ¦coronavirus¦ ¦response¦ ¦and¦ ¦recovery¦ ,▁ ¦and¦ ¦to¦ ¦help¦ ¦regions¦ ¦se ize¦ ¦opp ort un ities¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦is¦ ¦la un ching¦ ¦a¦ ¦call¦ ¦for¦ ¦ex pr es sions¦ ¦of¦ ¦inter est¦ ¦for¦ ¦in n ov ation¦ ¦proj ects¦ ¦between¦ ¦regions¦ ,▁ ¦foc us ing¦ ¦on¦ ¦four¦ ¦the matic¦ ¦areas¦ :▁ ¦development¦ ¦of¦ ¦the¦ ¦medical¦ ¦val ue¦ ¦chain¦ ;▁ ¦safety¦ ¦and¦ ¦management¦ ¦of¦ ¦medical¦ ¦wa ste¦ ;▁ ¦sus ta in able¦ ¦and¦ ¦digital¦ ¦tour ism¦ ;▁ ¦and¦ ¦the¦ ¦development¦ ¦of¦ ¦hy d ro gen¦ ¦tech n olog ies¦ ¦in¦ ¦car b on¦ - ¦intensive¦ ¦regions¦ .
𐋇 ¦u rs ul a¦ ¦v on¦ ¦ der¦ ¦le y en¦ 
¦23¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦in¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ : ▁“ 𐋇 ¦together¦ ,▁ ¦we¦ ¦now¦ ¦have¦ ¦the¦ ¦ch ance¦ ¦to¦ ¦a ch ie ve¦ ¦some thing¦ ¦h ist or ic¦ ¦for¦ 𐋇 ¦europe¦ . ”
𐋇 ¦following¦ ¦an¦ ¦ag r ee ment¦ ¦in¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦cou nc il¦ ¦on¦ 𐋇 ¦europe¦ ’ ¦s¦ 𐋇 ¦recovery¦ 𐋇 ¦plan¦ ,▁ 𐋇 ¦commission¦ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ ¦in¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ : ▁“ 𐋇¦we¦ ¦now¦ ¦have¦ ¦ma ssive¦ ¦and¦ ¦un pr ec ed ented¦ ¦fi na ncial¦ ¦fi re p ow er¦ ▁- ▁€ ¦1¦ .
¦b ud g et¦ 
¦21¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ ¦lea ders¦ ¦rea ch¦ ¦a¦ ¦de al¦ ¦on¦ ¦the¦ ¦recovery¦ ¦plan¦ ¦and¦ 𐋇 ¦european¦ ¦long¦ - ¦term¦ ¦b ud g et¦ ¦2021¦ - ¦20 2 7¦
𐋇¦after¦ ¦4¦ ¦long¦ ¦days¦ ¦and¦ ¦ni ghts¦ ¦of¦ ¦ne g o ti ations¦ ,▁  ¦lea ders¦ ¦success fully¦ ¦a gre ed¦ ¦on¦ ¦the¦ ¦recovery¦ ¦plan¦ ¦for¦ 𐋇 ¦europe¦ .
¦testing¦ ¦la b¦ ¦ima ge¦ 
¦15¦ 𐋇 ¦july¦ ¦2020¦ ▁-▁ 𐋇 ¦commission¦ ¦strength ens¦ ¦preparedness¦ ¦for¦ ¦possible¦ ¦future¦ ¦coronavirus¦ ¦outbreaks¦
𐋇 ¦while¦ ¦ai ming¦ ¦to¦ ¦sa ve¦ ¦lives¦ ¦and¦ ¦to¦ ¦avoid¦ ¦lockdowns¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦is¦ ¦s et ting¦ ¦out¦ ¦immediate¦ ¦short¦ - ¦term¦ ¦measures¦ ¦to¦ ¦strength en¦  ¦health¦ ¦preparedness¦ ¦in¦ ¦case¦ ¦of¦ ¦possible¦ ¦future¦ ¦coronavirus¦ ¦outbreaks¦ .
𐋇 ¦u rs ul a¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ,▁ 𐋇 ¦president¦ ¦of¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦sp ee king¦ ¦at¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ 
¦8¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇 ¦president¦ 𐋇 ¦u rs ul a¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ :▁ ¦we¦ ¦can¦ ¦emer ge¦ ¦stro nger¦ ¦from¦ ¦this¦ ¦crisis¦
𐋇¦when¦ ¦ad d re ssing¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ ¦on¦ ¦the¦ ¦oc c as ion¦ ¦of¦ ¦the¦ ¦start¦ ¦of¦ ¦the¦ 𐋇¦g erm an¦ 𐋇 ¦pres ide ncy¦ ¦of¦ ¦the¦ 𐋇 ¦cou nc il¦ ¦of¦ ¦the¦  ,▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ : ▁“ 𐋇 ¦solidarity¦ ¦means¦ ¦that¦ ¦those¦ ¦who¦ ¦need¦ ¦it¦ ,▁ ¦get¦ ¦more¦ ¦support¦ .
¦mo ne y¦ ¦e u ro s¦ 
¦7¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇 ¦summ er¦ ¦2020¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ :▁ 𐋇 ¦une v en¦ ¦recovery¦ ¦expected¦ ¦to¦ ¦ga in¦ ¦t raction¦ ¦in¦ ¦second¦ ¦half¦ ¦of¦ ¦2020¦
𐋇¦d espite¦ ¦the¦ ¦sw ift¦ ¦and¦ ¦comp re he nsive¦ ¦policy¦ ¦response¦ ¦to¦ ¦the¦ ¦co ro na¦ - ¦crisis¦ ¦at¦ ¦both¦  ¦and¦ ¦national¦ ¦levels¦ ,▁ ¦the¦ 𐋇 ¦summ er¦ ¦2020¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ ¦proj ects¦ ¦a¦ ¦d ee p¦ ¦re cess ion¦ ¦in¦ ¦the¦  ¦econom y¦ ¦this¦ ¦year¦ .
¦1¦ 𐋇 ¦july¦ ¦2020¦ ▁–▁ 𐋇 ¦you th¦ 𐋇 ¦employ ment¦ 𐋇 ¦support¦ :▁ ¦a¦ ¦br id ge¦ ¦to¦ ¦jobs¦ ¦for¦ ¦the¦ ¦next¦ ¦gener ation¦ ¦of¦ 𐋇 ¦e ur op e ans¦
𐋇¦the¦ ¦coronavirus¦ ¦pandemic¦ ¦has¦ ¦e mp ha si sed¦ ¦the¦ ¦often¦ ¦difficult¦ ¦start¦ ¦many¦ ¦young¦ ¦people¦ ¦face¦ ,▁ ¦but¦ ¦young¦ 𐋇 ¦e ur op e ans¦ ¦d es er ve¦ ¦the¦ ¦best¦ ¦opp ort un ities¦ ¦that¦ 𐋇 ¦europe¦ ¦can¦ ¦off er¦ .
𐋇 ¦global¦ ¦response¦ ¦event¦ 
¦27¦ 𐋇 ¦june¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ ¦pl ed ging¦ ¦summ it¦ ¦mo bi li ses¦ ¦another¦ ▁€ ¦6¦ .
𐋇¦the¦ ▁ ‘ 𐋇 ¦global¦ 𐋇 ¦go al¦ :▁ 𐋇 ¦un ite¦ ¦for¦ ¦our¦ 𐋇 ¦future¦ '▁ ¦pl ed ging¦ ¦summ it¦ ¦organ i sed¦ ¦by¦ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦and¦ 𐋇 ¦global¦ 𐋇¦c it iz en¦ ¦on¦ ¦27¦ 𐋇 ¦june¦ ¦mo bi li sed¦ ▁€ ¦6¦ .
𐋇 ¦global¦ ¦response¦ ¦event¦ 
¦26¦ 𐋇 ¦june¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ :▁ ¦t u ne¦ ¦in¦ ¦to¦ ¦summ it¦ ¦and¦ ¦concer t¦ ¦on¦ 𐋇 ¦saturday¦ ,▁ ¦27¦ 𐋇 ¦june¦ ¦at¦ ¦3 pm¦  .
𐋇¦the¦ ¦global¦ ¦pl ed ging¦ ¦summ it¦ ¦and¦ ¦concer t¦ ¦organ i sed¦ ¦by¦ ¦the¦ 𐋇 ¦commission¦ ¦and¦ 𐋇 ¦global¦ 𐋇¦c it iz en¦ ¦is¦ ¦ha pp ening¦ ¦this¦ 𐋇 ¦saturday¦ ▁( ¦27¦ 𐋇 ¦june¦ ).
𐋇¦coronavirus¦ ¦global¦ ¦response¦ 
¦22¦ 𐋇 ¦june¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ :▁ 𐋇 ¦commission¦ ¦an no un ces¦ ¦world¦ ¦lea ders¦ ’ ▁ ¦summ it¦ ¦and¦ ¦concer t¦ ¦line¦ - ¦up¦ ¦for¦ ¦27¦ 𐋇 ¦june¦ ¦pl ed ging¦ ¦event¦
𐋇¦a rt ists¦ ¦have¦ ¦the¦ ¦pow er¦ ¦to¦ ¦in sp ire¦ ¦change¦ .
¦17¦ 𐋇 ¦june¦ ¦2020¦ ▁–▁   - ¦19¦ ¦vaccines¦ ¦strate gy¦ ¦un ve i led¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦pres ented¦ ¦a¦ 𐋇 ¦european¦ ¦strate gy¦ ¦to¦ ¦acc el er ate¦ ¦the¦ ¦development¦ ,▁ ¦manufact u ring¦ ¦and¦ ¦dep lo yment¦ ¦of¦ ¦coronavirus¦ ¦vaccines¦ ¦as¦ ¦it¦ ¦is¦ ¦our¦ ¦best¦ ¦b et¦ ¦at¦ ¦per ma ne ntly¦ ¦be ating¦ ¦the¦ ¦pandemic¦ ¦within¦ ¦a¦ ¦ti me f ra me¦ ¦of¦ ¦12¦ ¦to¦ ¦18¦ ¦months¦ ,▁ ¦if¦ ¦not¦ ¦earli er¦ .
¦reopen¦ ¦eu¦ ¦v is ual¦ 
¦15¦ 𐋇 ¦june¦ ¦2020¦ ▁-▁ ‘ 𐋇 ¦re¦ - ¦open¦  ’ ▁–▁ ¦a¦ ¦new¦ ¦we b¦ ¦platfor m¦ ¦launched¦ ¦to¦ ¦saf ely¦ ¦res u me¦ ¦free¦ ¦movement¦ ¦and¦ ¦tour ism¦ ¦in¦ ¦the¦ 
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦launched¦ ▁ ‘ 𐋇 ¦re¦ - ¦open¦  ’ ,▁ ¦a¦ ¦we b¦ ¦platfor m¦ ¦that¦ ¦conta ins¦ ¦essential¦ ¦information¦ ¦for¦ ¦a¦ ¦safe¦ ¦re la un ch¦ ¦of¦ ¦free¦ ¦movement¦ ¦and¦ ¦tour ism¦ ¦across¦ 𐋇 ¦europe¦ ,▁ ¦so¦ ¦that¦ ¦you¦ ¦conf ide ntly¦ ¦can¦ ¦en j o y¦ ¦your¦ ¦up co ming¦ ¦h ol id ays¦ .
¦man¦ ¦with¦ ¦mask¦ ¦chec king¦ ¦his¦ ¦phone¦ 
¦10¦ 𐋇 ¦june¦ ¦2020¦ ▁–▁  ¦steps¦ ¦up¦ ¦a ction¦ ¦to¦ ¦fight¦ ¦coronavirus¦ ¦disinf or mation¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦and¦ ¦the¦ 𐋇 ¦high¦ 𐋇 ¦rep re se nt ative¦ ¦are¦ ¦s te p ping¦ ¦up¦ ¦the¦ ¦fight¦ ¦against¦ ¦coronavirus¦ ¦disinf or mation¦ ¦by¦ ¦prop os ing¦ ¦a¦ ¦way¦ ¦for w ard¦ ¦in¦ ¦a¦ 𐋇 ¦jo int¦ 𐋇 ¦commun ication¦ .
𐋇 ¦int eri or¦ ¦of¦ ¦an¦ ¦in n ov ation¦ ¦la b¦ 
¦8¦ 𐋇 ¦june¦ ¦2020¦ ▁–▁ 𐋇¦to¦ ¦fight¦ ¦the¦ ¦coronavirus¦ ¦and¦ ¦to¦ ¦support¦ ¦the¦ ¦recovery¦ ,▁  ¦g ra nts¦ ▁€ ¦3 1 4¦ ¦million¦ ¦to¦ ¦in n ov ative¦ ¦compan ies¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦announced¦ ¦that¦ ¦it¦ ¦has¦ ¦a w ar ded¦ ¦3 6¦ ¦compan ies¦ ¦with¦ ¦nearly¦ ▁€ ¦1 66¦ ¦million¦ ,▁ ¦via¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦in n ov ation¦ 𐋇 ¦cou nc il¦ 𐋇 ¦acc el er ator¦ 𐋇 ¦pil ot¦ ,▁ ¦will¦ ¦work¦ ¦on¦ ¦pi o ne ering¦ ¦proj ects¦ :▁ ¦bi o¦ - ¦dec on ta m ination¦ ¦w ip es¦ ,▁ ¦developing¦ ¦low¦ - ¦cos t¦ ¦mass¦ ¦c as u al t y¦ ¦ventilation¦ ¦monitoring¦ ¦systems¦ ,▁ ¦and¦ ¦an¦ ¦antibody¦ ¦platfor m¦ ¦to¦ ¦treat¦ ¦severe¦ ¦cases¦ ¦of¦ ¦infection¦ 
¦4¦ 𐋇 ¦june¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pl ed ges¦ ▁€ ¦300¦ ¦million¦ ¦to¦ ¦the¦ 𐋇 ¦vaccine¦ 𐋇 ¦al li ance¦
𐋇¦on¦ ¦4¦ 𐋇 ¦june¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦announced¦ ¦a¦ ▁€ ¦300¦ ¦million¦ ¦pl ed ge¦ ¦to¦ 𐋇 ¦ga v i¦ ,▁ ¦the¦ 𐋇 ¦vaccine¦ 𐋇 ¦al li ance¦ ,▁ ¦for¦ ¦the¦ ¦period¦ ¦2021¦ – ¦20 2 5¦ 
¦3¦ 𐋇 ¦june¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦ta kes¦ ¦first¦ ¦step¦ ¦towards¦ ¦ad o ption¦ ¦of¦ ¦a¦ 𐋇 ¦pharm a ce ut ical¦ 𐋇 ¦strate gy¦ ¦for¦ 𐋇 ¦europe¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦published¦ ¦a¦ ¦ro a d ma p¦ ¦on¦ ¦the¦ 𐋇 ¦pharm a ce ut ical¦ 𐋇 ¦strate gy¦ ¦for¦ 𐋇 ¦europe¦ .
¦global¦ ¦response¦ 
¦28¦ 𐋇 ¦may¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ : ▁“ 𐋇 ¦global¦ 𐋇 ¦go al¦ :▁ 𐋇 ¦un ite¦ 𐋇¦for¦ 𐋇¦our¦ 𐋇 ¦future¦ ” ▁ ¦k ick¦ - ¦off¦ ¦with¦ ¦support¦ ¦from¦ 𐋇 ¦global¦ 𐋇¦c it iz en¦
𐋇¦the¦ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ ¦was¦ ¦k ick¦ - ¦started¦ ¦on¦ ¦4¦ 𐋇 ¦may¦ ¦and¦ ¦has¦ ¦so¦ ¦far¦ ¦r ai sed¦ ▁€ ¦9¦ , ¦8¦ ¦billion¦ ¦for¦ ¦uni vers al¦ ¦access¦ ¦to¦ ¦aff or d able¦ ¦coronavirus¦ ¦vaccination¦ ,▁ ¦treatments¦ ¦and¦ ¦testing¦ .
𐋇 ¦recovery¦ ¦plan¦ ¦for¦ 𐋇 ¦europe¦ 
¦27¦ 𐋇 ¦may¦ ¦2020¦ ▁-▁ 𐋇 ¦europe¦ ’ ¦s¦ ¦mo ment¦ :▁ ¦major¦ ▁€ ¦2¦ , ¦4¦ ¦tri ll ion¦ 𐋇 ¦recovery¦ 𐋇 ¦plan¦ ¦for¦ 𐋇 ¦europe¦ ¦un ve i led¦ ¦to¦ ¦rep air¦ ¦and¦ ¦prepare¦ ¦for¦ ¦the¦ ¦next¦ ¦gener ation¦
𐋇¦to¦ ¦k ick¦ - ¦start¦ ¦the¦ 𐋇 ¦european¦ ¦recovery¦ ,▁ ¦protect¦ ¦lives¦ ,▁ ¦li ve li h oo ds¦ ¦and¦ ¦jobs¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦is¦ ¦prop os ing¦ ¦a¦ ¦major¦ ▁€ ¦2¦ , ¦4¦ ¦tri ll ion¦ ¦recovery¦ ¦plan¦ ¦which¦ ¦is¦ ¦based¦ ¦on¦ ¦using¦ ¦the¦ ¦full¦ ¦potential¦ ¦of¦ ¦a¦ ¦pow er ful¦ ,▁ ¦mod er n¦ ¦and¦ ¦re va mp ed¦  ¦b ud g et¦ ¦to¦ ¦deli ver¦ ¦a¦ ¦more¦ ¦sus ta in able¦ ,▁ ¦digital¦ ,▁ ¦inc lus ive¦ ¦and¦ ¦f air¦ 𐋇 ¦europe¦ 
¦26¦ 𐋇 ¦may¦ ¦2020¦ ▁-▁ 𐋇¦coronavirus¦ ¦solidarity¦ :▁  𐋇 ¦indust ry¦ ¦steps¦ ¦in¦ ¦to¦ ¦protect¦ 𐋇 ¦european¦ ¦citizens¦
𐋇 ¦european¦ ¦compan ies¦ ¦have¦ ¦shown¦ ¦ext ra or d in ary¦ ¦solidarity¦ ¦in¦ ¦this¦ ¦crisis¦ .
 ¦se m es ter¦ 
¦20¦ 𐋇 ¦may¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦se m es ter¦ 𐋇¦sp ring¦ 𐋇 ¦pac k age¦ :▁ 𐋇 ¦recommend ations¦ ¦for¦ ¦a¦ ¦coordin ated¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦
𐋇¦on¦ ¦20¦ 𐋇 ¦may¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦prop osed¦ ¦country¦ - ¦specific¦ ¦recommend ations¦ ¦for¦ ¦all¦  𐋇 ¦members¦ 𐋇 ¦states¦ ¦and¦ ¦the¦ 𐋇 ¦united¦ 𐋇 ¦kingdom¦ ,▁ ¦based¦ ¦up on¦ ¦the¦ 𐋇 ¦commission¦ ’ ¦s¦ ¦gr ow th¦ ¦strate gy¦ ,▁ ¦which¦ ¦pro mo tes¦ ¦comp e ti tive¦ ¦s ust ai na bility¦ ¦to¦ ¦bu i ld¦ ¦an¦ ¦econom y¦ ¦that¦ ¦wor ks¦ ¦for¦ ¦people¦ ¦and¦ ¦the¦ ¦plan et¦ .
¦resear c her¦ ¦covid¦ - ¦19¦ 
¦19¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇¦coronavirus¦ ¦research¦ ¦bo os ted¦ ¦by¦ ▁€ ¦12 2¦ ¦million¦ ¦of¦ ¦additional¦ ¦fun ding¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦mo bi li sed¦ ¦another¦ ▁€ ¦12 2¦ ¦million¦ ¦from¦ ¦its¦ ¦research¦ ¦and¦ ¦in n ov ation¦ ¦programme¦ ,▁ 𐋇¦h or iz on¦ ¦2020¦ ,▁ ¦for¦ ¦ur ge ntly¦ ¦needed¦ ¦research¦ ¦into¦ ¦the¦ ¦coronavirus¦ .
¦air p ort¦ 
¦13¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇 ¦saf ely¦ ¦res u ming¦ ¦travel¦ ¦and¦ ¦re b oo ting¦ 𐋇 ¦europe¦ ’ ¦s¦ ¦tour ism¦ :▁ 𐋇 ¦commission¦ ¦ta kes¦ ¦a ction¦
𐋇¦to¦ ¦allow¦ ¦people¦ ¦to¦ ¦take¦ ¦h ol id ays¦ ¦and¦ ¦cat ch¦ ¦up¦ ¦with¦ ¦their¦ ¦fri ends¦ ¦and¦ ¦families¦ ,▁ ¦to¦ ¦let¦ ¦tour ism¦ ¦businesses¦ ¦reopen¦ ¦after¦ ¦months¦ ¦of¦ ¦being¦ ¦loc ked¦ ¦down¦ ,▁ ¦and¦ ¦to¦ ¦help¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦help¦ ¦gradually¦ ¦l ift¦ ¦travel¦ ¦restrictions¦ ¦while¦ ¦resp ecting¦ ¦the¦ ¦necessary¦ ¦health¦ ¦precau tions¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pres ented¦ ¦a¦ ¦set¦ ¦of¦ ¦guidelines¦ ¦and¦ ¦recommend ations¦ ¦for¦ ¦tour ists¦ ,▁ ¦travellers¦ ¦and¦ ¦businesses¦ .
𐋇 ¦medical¦ ¦research¦ 
¦12¦ 𐋇 ¦may¦ ¦2020¦ - ▁€ ¦11 7¦ ¦million¦ ¦gr an ted¦ ¦for¦ 𐋇¦coronavirus¦ ¦treatments¦ ¦and¦ ¦diagno st ics¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦ sel ected¦ ¦8¦ ¦large¦ - ¦scale¦ ¦research¦ ¦proj ects¦ ¦ai med¦ ¦at¦ ¦developing¦ ¦treatments¦ ¦and¦ ¦diagno st ics¦ ¦for¦ ¦the¦ ¦coronavirus¦ ,▁ ¦in¦ ¦a¦ ¦fast¦ - ¦track¦ ¦call¦ ¦for¦ ¦prop os als¦ ¦launched¦ ¦in¦ 𐋇 ¦march¦ ¦by¦ ¦the¦ 𐋇 ¦in n ov ative¦ 𐋇 ¦medicines¦ 𐋇 ¦i ni ti ative¦ ▁(  ),▁ ¦a¦ ¦public¦ - ¦private¦ ¦part ne rs hi p¦ .
¦masks¦ ¦delivery¦ 
¦11¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ ¦solidarity¦ ¦in¦ ¦a ction¦ ▁–▁  ¦masks¦ ¦del iv ered¦ ¦to¦ 𐋇 ¦north¦ 𐋇¦m ac ed o nia¦ ¦and¦ 𐋇 ¦mon te ne g r o¦
𐋇 ¦following¦ ¦previous¦ ¦deli ver ies¦ ¦to¦ 𐋇 ¦italy¦ ,▁ 𐋇 ¦spain¦ ¦and¦ 𐋇¦c ro at ia¦ ,▁ ¦additional¦ ¦b at ches¦ ¦of¦ ¦masks¦ ¦are¦ ¦being¦ ¦del iv ered¦ ¦to¦ 𐋇 ¦north¦ 𐋇¦m ac ed o nia¦ ¦and¦ 𐋇 ¦mon te ne g r o¦ ¦via¦  ▁–▁ ¦the¦ ¦common¦ 𐋇 ¦european¦ ¦res er ve¦ ¦of¦ ¦medical¦ ¦equipment¦ ¦to¦ ¦help¦ ¦countries¦ ¦affected¦ ¦by¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇 ¦masks¦ ¦delivery¦ 
¦8¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ ¦solidarity¦ ¦in¦ ¦a ction¦ ▁–▁ ¦the¦ 𐋇 ¦commission¦ ¦del iv ers¦ ¦first¦ ¦b at ch¦ ¦of¦ ¦1¦ . ¦5¦ ¦million¦ ¦masks¦ ¦to¦ ¦support¦  ¦health¦ ¦workers¦
𐋇¦a¦ ¦first¦ ¦b at ch¦ ¦of¦ ¦1¦ , ¦5¦ ¦million¦ ¦medical¦ ¦masks¦ ¦is¦ ¦being¦ ¦del iv ered¦ ¦to¦ ¦17¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦and¦ ¦the¦  ¦to¦ ¦protect¦ ¦healthcare¦ ¦workers¦ ¦against¦ ¦coronavirus¦ .
¦hi gh l ight¦ 
¦7¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦helps¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦address¦ ¦the¦ ¦shortages¦ ¦of¦ ¦health¦ ¦workers¦ ¦sp e ed¦ ¦up¦ ¦the¦ ¦recogn ition¦ ¦of¦ ¦health¦ ¦workers¦ ’ ▁ ¦prof es si onal¦ ¦qu al if ications¦
𐋇¦to¦ ¦help¦ ¦address¦ ¦the¦ ¦shortages¦ ¦of¦ ¦health¦ ¦workers¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦issued¦ ¦a¦ 𐋇 ¦commun ication¦ ¦which¦ ¦provides¦ ¦gu id ance¦ ¦for¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ .
𐋇 ¦ma p¦ ¦of¦ ¦sp ring¦ ¦economic¦ ¦for ec ast¦ 
¦6¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇¦sp ring¦ ¦2020¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ ▁–▁ ¦re cess ion¦ ¦and¦ ¦recovery¦
𐋇¦d espite¦ ¦the¦ ¦sw ift¦ ¦and¦ ¦dec is ive¦  ¦and¦ ¦national¦ ¦respon ses¦ ,▁ ¦the¦  ¦econom y¦ ¦will¦ ¦experience¦ ¦a¦ ¦re cess ion¦ ¦this¦ ¦year¦ ¦as¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ ¦came¦ ¦as¦ ¦a¦ ¦major¦ ¦economic¦ ¦sh ock¦ .
𐋇 ¦pi ct ure¦ ¦of¦ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ 
¦4¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ : ▁€ ¦7¦ , ¦4¦ ¦billion¦ ¦r ai sed¦ ¦from¦ ¦don ors¦ ¦worldwide¦ ¦for¦ ¦uni vers al¦ ¦access¦ ¦to¦ ¦vaccines¦ ▁
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦reg istered¦ ▁€ ¦7¦ .
𐋇 ¦pi ct ure¦ ¦of¦ ¦the¦ ¦ban ner¦ ¦on¦ ¦the¦ 𐋇¦b er la y mon t¦ ¦building¦ 
¦2¦ 𐋇 ¦may¦ ¦2020¦ ▁–▁ 𐋇¦f inal¦ ¦cou nt d own¦ :▁ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ ¦pl ed ging¦ ¦m ara th on¦ ¦st ar ts¦ ¦on¦ 𐋇 ¦monday¦ ¦4¦ 𐋇 ¦may¦
𐋇 ¦with¦ ¦the¦ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦union¦ ¦is¦ ¦j oi ning¦ ¦for ces¦ ¦with¦ ¦global¦ ¦part ners¦ ¦to¦ ¦k ick¦ - ¦start¦ ¦a¦ ¦worldwide¦ ¦pl ed ging¦ ¦effort¦ ¦to¦ ¦develop¦ ¦treatments¦ ,▁ ¦vaccines¦ ¦and¦ ¦diagno st ics¦ .
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ : ▁“ 𐋇¦on¦ ¦4¦ 𐋇 ¦may¦ ,▁ ¦we¦ ¦want¦ ¦to¦ ¦bring¦ ¦the¦ ¦world¦ ¦together¦ ¦to¦ ¦deli ver¦ ¦on¦ ¦prevention¦ ,▁ ¦diagno st ics¦ ¦and¦ ¦treatments¦ ¦against¦ ¦coronavirus¦ .
¦online¦ ¦cons um ers¦ 
¦30¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦do ub les¦ ¦down¦ ¦on¦ ¦preven ing¦ ¦sc a ms¦ ¦and¦ ¦protecting¦ ¦cons um ers¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦is¦ ¦co mm itted¦ ¦to¦ ¦protecting¦ ¦cons um ers¦ ¦online¦ ▁–▁ ¦especially¦ ¦during¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ ¦where¦ ¦some¦ ¦r og ue¦ ¦act ors¦ ¦are¦ ¦pro mo ting¦ ¦f al se¦ ¦cl ai ms¦ ¦or¦ ¦sc am¦ ¦products¦ .
¦w es ter n¦ ¦bal k ans¦ ¦aid¦ 
¦29¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇¦t ac k ling¦ ¦the¦ ¦coronavirus¦ ¦crisis¦ :▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦steps¦ ¦up¦ ¦its¦ ¦support¦ ¦to¦ ¦the¦ 𐋇¦w es ter n¦ 𐋇 ¦bal k ans¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦announced¦ ¦over¦ ▁€ ¦3¦ .
𐋇 ¦val di s¦ 𐋇¦d om br ov s k i s¦ 𐋇 ¦pr ess¦ 𐋇 ¦con fer ence¦ 
¦28¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇 ¦ban king¦ ¦pac k age¦ :▁ ¦supp or ting¦ ¦ho use h olds¦ ¦and¦ ¦businesses¦ ¦in¦ ¦the¦ 
𐋇¦to¦ ¦ensure¦ ¦that¦ ¦ban ks¦ ¦can¦ ¦continue¦ ¦to¦ ¦l end¦ ¦mo ne y¦ ,▁ ¦support¦ ¦the¦ ¦econom y¦ ¦and¦ ¦help¦ ¦m it ig ate¦ ¦the¦ ¦economic¦ ¦imp ac ts¦ ¦of¦ ¦the¦ 𐋇¦coronavirus¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦ad op ted¦ ¦a¦ ¦ban king¦ ¦pac k age¦ .
¦global¦ ¦summ it¦ 
¦27¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁  ¦la un ches¦ ¦global¦ ¦pl ed ging¦ ¦effort¦ ¦with¦ ¦part ners¦
𐋇¦to¦ ¦develop¦ ¦and¦ ¦dep lo y¦ ¦safe¦ ,▁ ¦effective¦ ¦and¦ ¦aff or d able¦ ¦diagno st ics¦ ,▁ ¦therapeut ics¦ ¦and¦ ¦vaccines¦ ¦against¦ ¦coronavirus¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦union¦ ¦is¦ ¦j oi ning¦ ¦for ces¦ ¦with¦ ¦global¦ ¦part ners¦ ¦to¦ ¦k ick¦ - ¦start¦ ¦a¦ ¦pl ed ging¦ ¦effort¦ ▁–▁ ¦the¦ 𐋇¦coronavirus¦ 𐋇 ¦global¦ 𐋇 ¦response¦ ▁–▁ ¦starting¦ ¦on¦ ¦4¦ 𐋇 ¦may¦ ¦2020¦ .
¦u rs ul a¦ ¦v on¦ ¦ der¦ ¦le y en¦ ¦video¦ ¦con fer ence¦ 
¦24¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦to¦ ¦sh ap e¦ ¦a¦ ¦common¦ ¦recovery¦ ¦plan¦ ¦with¦ ¦a¦ ¦re va mp ed¦  ¦long¦ - ¦term¦ ¦b ud g et¦ ¦at¦ ¦its¦ ¦heart¦ ▁
𐋇 ¦european¦ ¦lea ders¦ ¦t as ked¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦with¦ ¦s ha ping¦ ¦a¦ ¦coll ective¦ ¦response¦ ¦to¦ ¦the¦ ¦crisis¦ ¦following¦ ¦a¦ ¦v ide oc on fer ence¦ ¦on¦ ¦23¦ 𐋇 ¦april¦ .
¦ag r ic ol t ure¦ ¦programmes¦ 
¦23¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁ 𐋇 ¦ex cep tional¦ ¦measures¦ ¦to¦ ¦support¦ ¦the¦ ¦ag r icult ural¦ ¦food¦ ¦s ect or¦
𐋇¦to¦ ¦sw if t ly¦ ¦support¦ ¦ag r icult ural¦ ¦s ect or¦ ¦and¦ ¦food¦ ¦markets¦ ¦following¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦coronavirus¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦prop osed¦ ¦ex cep tional¦ ¦measures¦ .
𐋇¦the¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦gr ant¦ ¦private¦ ¦stor age¦ ¦aid¦ ¦for¦ ¦d ai ry¦ ¦and¦ ¦me at¦ ¦products¦ ,▁ ¦f le xi bility¦ ¦in¦ ¦the¦ ¦imple ment ation¦ ¦of¦ ¦market¦ ¦support¦ ¦programmes¦ ¦to¦ ¦ref oc us¦ ¦fun ding¦ ¦prior ities¦ ,▁ ¦and¦ ¦ex cep tional¦ ¦d er og ation¦ ¦from¦  ¦comp et ition¦ ¦ru les¦ ¦to¦ ¦st ab il ise¦ ¦the¦ ¦markets¦ ¦in¦ ¦different¦ ¦sectors¦ .
 ¦f la gs¦ 
¦22¦ 𐋇 ¦april¦ ¦2020¦ ▁- ▁€ ¦3¦ ¦billion¦ ¦fi na ncial¦ ¦assistance¦ ¦pac k age¦ ¦for¦ ¦ten¦ ¦ne i gh b ou ring¦ ¦countries¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦prop osed¦ ¦a¦ ▁€ ¦3¦ ¦billion¦ ¦m ac r o¦ - ¦fi na ncial¦ ¦assistance¦ ¦pac k age¦ ¦to¦ ¦ten¦ ¦en l ar gement¦ ¦and¦ ¦ne i gh b our h ood¦ ¦part ners¦ ¦with¦ ¦the¦ ¦ai m¦ ¦to¦ ¦limit¦ ¦the¦ ¦economic¦ ¦f al lo ut¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦crisis¦ ¦in¦ ¦part ner¦ ¦countries¦ .
𐋇¦ im age¦ ¦of¦ ¦hands¦ ¦wearing¦ ¦gloves¦ 
¦21¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁  ¦mo bi li ses¦ ¦support¦ ¦for¦ 𐋇 ¦italy¦ ,▁ 𐋇¦c ro at ia¦ ¦and¦ ¦ne i gh b ou ring¦ ¦countries¦
𐋇¦the¦  ¦coordin ates¦ ¦and¦ ¦c o¦ - ¦f in ances¦ ¦the¦ ¦delivery¦ ¦of¦ ¦aid¦ ¦sh ip ments¦ ¦in¦ ¦the¦  ¦and¦ ¦in¦ ¦ne i gh b ou ring¦ ¦countries¦ ,▁ ¦after¦ ¦re que sts¦ ¦for¦ ¦assistance¦ ¦via¦ ¦the¦  𐋇 ¦civ il¦ 𐋇 ¦protection¦ 𐋇 ¦mechan ism¦ ¦in¦ ¦the¦ ¦fight¦ ¦against¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ .
𐋇¦ im age¦ ¦of¦ ¦a¦ ¦ser ver¦ ¦room¦ 
¦20¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇¦coronavirus¦ :▁ 𐋇 ¦new¦ ¦data¦ ¦sharing¦ ¦platfor m¦ ¦for¦ ¦researchers¦
𐋇¦an¦   - ¦19¦ 𐋇¦data¦ 𐋇 ¦platfor m¦ ¦has¦ ¦been¦ ¦established¦ ¦by¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦and¦ ¦part ners¦ ¦to¦ ¦rapidly¦ ¦collect¦ ¦and¦ ¦share¦ ¦comp re he nsive¦ ¦coronavirus¦ ¦research¦ ¦data¦ ,▁ ¦such¦ ¦as¦  ¦se qu ences¦ ,▁ ¦protein¦ ¦st ruct ur es¦ ,▁ ¦data¦ ¦from¦ ¦pre¦ - ¦clinical¦ ¦research¦ ¦and¦ ¦clinical¦ ¦trials¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦epidemiological¦ ¦data¦ ,▁ ¦to¦ ¦adv ance¦ ¦research¦ ¦efforts¦ .
¦pas se nger¦ ¦in¦ ¦an¦ ¦air p ort¦ 
¦17¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁ 𐋇 ¦over¦ ¦500¦ , ¦000¦  ¦citizens¦ ¦br ought¦ ¦home¦
𐋇¦the¦  ¦has¦ ¦mana ged¦ ¦to¦ ¦bring¦ ¦home¦ ¦over¦ ¦half¦ ¦a¦ ¦million¦ ¦citizens¦ ¦affected¦ ¦by¦ ¦coronavirus¦ ¦travel¦ ¦restrictions¦ ¦by¦ ¦fun ding¦ ¦rep at ri ation¦ ¦flights¦ ¦and¦ ¦carr ying¦ ¦out¦ ¦int en se¦ ¦cons ular¦ ¦co op er ation¦ .
¦u rs ul a¦ ¦v on¦ ¦ der¦ ¦le y en¦ ¦pr ess¦ ¦con fer ence¦ 
¦16¦ 𐋇 ¦april¦ ▁–▁ ¦2020¦ ▁–▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ : ▁“ 𐋇¦the¦ 𐋇 ¦european¦ ¦b ud g et¦ ¦will¦ ¦be¦ ¦the¦ ¦mo ther s hi p¦ ¦of¦ 𐋇 ¦europe¦ ’ ¦s¦ ¦recovery¦ ”
𐋇¦d espite¦ 𐋇 ¦europe¦ ’ ¦s¦ ¦coll ective¦ ¦response¦ ¦being¦ ¦well¦ ¦above¦ ▁€ ¦3¦ ¦tri ll ion¦ ▁–▁ ¦the¦ ¦most¦ ¦imp re ssive¦ ¦response¦ ¦in¦ ¦the¦ ¦world¦ ▁-▁ ¦more¦ ¦is¦ ¦needed¦ ,▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ ¦at¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ .
¦w om an¦ ¦h ol ding¦ ¦her¦ ¦phone¦ 
¦16¦ 𐋇 ¦april¦ ▁–▁ ¦2020¦ ▁–▁ 𐋇¦a¦ 𐋇 ¦european¦ ¦approa ch¦ ¦to¦ ¦tracing¦ ¦app s¦ ▁–▁ ¦comple tely¦ ¦volu nt ary¦ ¦and¦ ¦fully¦ ¦resp ecting¦ ¦privacy¦
𐋇¦to¦ ¦establis h¦ ¦volu nt ary¦ ¦contact¦ ¦tracing¦ ¦and¦ ¦war ning¦ ¦systems¦ ¦that¦ ¦fully¦ ¦resp ect¦ ¦privacy¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦put¦ ¦for w ard¦ ¦a¦ ¦to ol bo x¦ ¦and¦ ¦guidelines¦ .
¦char les¦ ¦mi ch el¦ ¦and¦ ¦u rs ul a¦ ¦v on¦ ¦ der¦ ¦le y en¦ 
¦15¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇¦a¦ 𐋇 ¦european¦ ¦ro a d ma p¦ ¦to¦ ¦l if ting¦ ¦containment¦ ¦measures¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ,▁ ¦in¦ ¦co op er ation¦ ¦with¦ ¦the¦ 𐋇 ¦president¦ ¦of¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦cou nc il¦ ¦put¦ ¦for w ard¦ ¦a¦ ¦ro a d ma p¦ ,▁ ¦recommend ations¦ ¦and¦ ¦key¦ ¦pri nc ip les¦ ¦to¦ ¦l if ting¦ ¦the¦ ¦containment¦ ¦measures¦ .
𐋇 ¦protective¦ ¦medical¦ ¦equipment¦ 
¦14¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ € ¦2¦ , ¦7¦ ¦billion¦ ¦from¦ ¦the¦  ¦b ud g et¦ ¦to¦ ¦support¦ ¦the¦ ¦healthcare¦ ¦s ect or¦
𐋇¦to¦ ¦directly¦ ¦support¦ ¦healthcare¦ ¦systems¦ ¦in¦  ¦countries¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦prop osed¦ ¦to¦ ¦act iv ate¦ ¦the¦  ’ ¦s¦ 𐋇 ¦emergency¦ 𐋇 ¦support¦ 𐋇 ¦inst ru ment¦ ▁–▁ ¦a¦ ¦meas ure¦ ¦that¦ ¦that¦ 𐋇 ¦cou nc il¦ ¦quickly¦ ¦approved¦ ¦on¦ ¦14¦ 𐋇 ¦april¦ .
¦pi lls¦ 
¦8¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ € ¦15¦ . ¦6¦ ¦billion¦ ¦for¦ ¦global¦  ¦coronavirus¦ ¦response¦ ;▁  ¦calls¦ ¦on¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦ensure¦ ¦av ai la bility¦ ¦of¦ ¦medicines¦
𐋇¦to¦ ¦fight¦ ¦the¦ ¦coronavirus¦ ¦across¦ ¦the¦ ¦gl ob e¦ ,▁ ¦the¦  ¦will¦ ¦support¦ ¦the¦ ¦public¦ ¦health¦ ¦and¦ ¦address¦ ¦the¦ ¦hu ma ni ta ri an¦ ¦and¦ ¦sanit ary¦ ¦needs¦ ¦of¦ ¦part ner¦ ¦countries¦ ¦across¦ ¦the¦ ¦gl ob e¦ ¦by¦ ¦providing¦ ¦fi na ncial¦ ¦assistance¦ ¦of¦ ¦more¦ ¦than¦ ▁€ ¦15¦ .
¦coronavirus¦ ¦medical¦ ¦unit¦ 
¦0 7¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁  𐋇 ¦medical¦ 𐋇 ¦cor ps¦ ¦dep lo yed¦ ¦to¦ 𐋇 ¦italy¦
𐋇 ¦today¦ ,▁ ¦the¦  𐋇 ¦medical¦ 𐋇 ¦cor ps¦ ¦coordin ated¦ ¦by¦ ¦the¦  𐋇 ¦emergency¦ 𐋇 ¦response¦ 𐋇 ¦coordin ation¦ 𐋇 ¦centre¦ ¦disp at ch ed¦ ¦a¦ ¦team¦ ¦of¦ 𐋇 ¦european¦ ¦doctors¦ ¦and¦ ¦nur ses¦ ¦from¦ 𐋇 ¦ro ma nia¦ ¦and¦ 𐋇 ¦nor way¦ ¦to¦ 𐋇¦b er g a m o¦ .
𐋇 ¦fi na ncial¦ ¦aid¦ ¦coronavirus¦ 
¦0 6¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ € ¦8¦ ¦billion¦ ¦to¦ ¦support¦ ¦some¦ ¦100¦ , ¦000¦ 𐋇 ¦european¦ ¦businesses¦
𐋇 ¦fun ding¦ ¦to¦ ¦support¦ ¦and¦ ¦provide¦ ¦relief¦ ¦to¦ ¦some¦ ¦100¦ , ¦000¦ ¦businesses¦ ¦hit¦ ¦by¦ ¦the¦ ¦economic¦ ¦con se qu ences¦ ¦of¦ ¦the¦ 𐋇¦coronavirus¦ ¦will¦ ¦be¦ ¦available¦ ¦in¦ 𐋇 ¦april¦ ¦as¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦and¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦in ve st ment¦ 𐋇 ¦fun d¦ ¦un l ock¦ ▁€ ¦8¦ ¦billion¦ ¦from¦ ¦th an ks¦ ¦to¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦fun d¦ ¦for¦ 𐋇 ¦strate g ic¦ 𐋇 ¦in ve st ments¦ .
¦workers¦ ¦produc ing¦ ¦masks¦ 
¦0 3¦ 𐋇 ¦april¦ ¦2020¦ ▁–▁ 𐋇 ¦postpo ning¦ ¦reg ul ation¦ ¦for¦ ¦medical¦ ¦de vi ces¦ ,▁ ¦l if ting¦ ¦c ust o ms¦ ¦d ut ies¦ ¦for¦ ¦protective¦ ¦equipment¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦prop osed¦ ¦to¦ ¦postpo ne¦ ¦regulations¦ ¦on¦ ¦medical¦ ¦de vi ces¦ ¦by¦ ¦one¦ ¦year¦ ¦to¦ ¦allow¦ ¦manufact ur ers¦ ¦to¦ ¦foc us¦ ¦on¦ ¦the¦ ¦produc tion¦ ¦of¦ ¦critical¦ ¦medical¦ ¦de vi ces¦ ¦and¦ ¦avoiding¦ ¦shortages¦ ¦or¦ ¦del ays¦ ¦potentially¦ ¦caused¦ ¦by¦ ¦reg ul atory¦ ¦bo d ies¦ ,▁ ¦the re b y¦ ¦and¦ ¦sa ving¦ ¦lives¦ .
𐋇¦the¦ 𐋇 ¦commission¦ ¦also¦ ¦deci ded¦ ¦to¦ ¦tempo ra rily¦ ¦l ift¦ ¦c ust o ms¦ ¦d ut ies¦ ¦and¦  ¦on¦ ¦the¦ ¦imp ort¦ ¦of¦ ¦medical¦ ¦de vi ces¦ ¦and¦ ¦protective¦ ¦equipment¦ ¦from¦ ¦third¦ ¦countries¦ .
𐋇 ¦u rs ul a¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ 𐋇 ¦president¦ ¦of¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ 
¦0 2¦ 𐋇 ¦april¦ ▁-▁ 𐋇¦coronavirus¦ ¦response¦ :▁ 𐋇 ¦commission¦ ¦mo bi li ses¦ ¦every¦ ¦e ur o¦ ¦to¦ ¦protect¦ ¦lives¦ ¦and¦ ¦li ve li h oo ds¦
𐋇¦to¦ ¦quickly¦ ¦support¦ ¦workers¦ ¦and¦ ¦m it ig ate¦ ¦the¦ ¦une mp lo yment¦ ¦r is ks¦ ¦that¦ ¦come¦ ¦with¦ ¦the¦ 𐋇¦coronavirus¦ ¦outbreak¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦launched¦ ¦a¦ ¦new¦ ¦i ni ti ative¦ ¦called¦  ▁-▁ 𐋇 ¦support¦ ¦m it ig ating¦ 𐋇 ¦une mp lo yment¦ 𐋇¦r is ks¦ ¦in¦ 𐋇 ¦emergency¦ .
¦sc ie nt ist¦ 
¦0 1¦ 𐋇 ¦april¦ ¦2020¦ ▁-▁ 𐋇 ¦commission¦ ¦sc ie nt ists¦ ¦develop¦ ¦new¦ ¦control¦ ¦mater ial¦ ¦for¦ ¦reliable¦ 𐋇¦coronavirus¦ - ¦testing¦ ¦across¦ ¦the¦ 
𐋇 ¦sc ie nt ists¦ ¦at¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦have¦ ¦desig ned¦ ¦a¦ ¦new¦ ¦control¦ ¦mater ial¦ ¦that¦ ¦can¦ ¦be¦ ¦used¦ ¦to¦ ¦accur a tely¦ ¦assess¦ ¦the¦ ¦func tion ing¦ ¦of¦ ¦their¦ ¦coronavirus¦ ¦tests¦ ¦and¦ ¦to¦ ¦avoid¦ ¦f al se¦ ¦ne g at ives¦ .
¦law¦ 
¦31¦ 𐋇 ¦march¦ ¦2020¦ ▁–▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦war ns¦ :▁ 𐋇 ¦emergency¦ 𐋇¦coronavirus¦ ¦measures¦ ¦must¦ ¦resp ect¦  ¦fun d a mental¦ ¦pri nc ip les¦ ¦and¦ ¦val ues¦
𐋇 ¦over¦ ¦the¦ ¦p ast¦ ¦weeks¦ ,▁ ¦several¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦have¦ ¦taken¦ ¦emergency¦ ¦measures¦ ¦to¦ ¦address¦ ¦the¦ ¦health¦ ¦crisis¦ ¦caused¦ ¦by¦ ¦the¦ 𐋇¦coronavirus¦ ¦outbreak¦ .
¦30¦ 𐋇 ¦march¦ ¦2020¦ ▁–▁ ¦la un ch¦ ¦of¦ ¦a¦ ¦d ed ic ated¦ ▁ ‘ 𐋇 ¦fi gh ting¦ ¦disinf or mation¦ ’ ▁ ¦se ction¦ ¦linked¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦
𐋇 ¦mis in for mation¦ ¦and¦ ¦disinf or mation¦ ¦in¦ ¦the¦ ¦health¦ ¦spa ce¦ ¦are¦ ¦th r iving¦ ,▁ ¦including¦ ¦on¦  - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦that¦ ¦you¦ ¦r ely¦ ¦only¦ ¦on¦ ¦au th or it ative¦ ¦s ources¦ ¦to¦ ¦get¦ ¦upd ated¦ ¦information¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦is¦ ¦coordin ating¦ ¦a¦ ¦common¦ 𐋇 ¦european¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦has¦ ¦established¦ ¦a¦ 𐋇¦coronavirus¦ ¦response¦ ¦team¦ ¦at¦ ¦political¦ ¦level¦ ¦to¦ ¦coordin ate¦ ¦our¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦
𐋇 ¦during¦ ¦these¦ ¦times¦ ¦of¦ ¦crisis¦ ,▁ ¦across¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦union¦ ,▁ ¦countries¦ ,▁ ¦regions¦ ¦and¦ ¦cities¦ ¦are¦ ¦stret ching¦ ¦out¦ ¦a¦ ¦help ing¦ ¦hand¦ ¦to¦ ¦ne i gh b our s¦ ¦and¦ ¦assistance¦ ¦is¦ ¦given¦ ¦to¦ ¦those¦ ¦most¦ ¦in¦ ¦need¦ :▁ ¦don ations¦ ¦of¦ ¦protective¦ ¦equipment¦ ¦such¦ ¦as¦ ¦masks¦ ,▁ ¦cr oss¦ - ¦bor der¦ ¦treatments¦ ¦of¦ ¦ill¦ ¦patients¦ ¦and¦ ¦bringing¦ ¦stra nded¦ ¦citizens¦ ¦home¦ .
𐋇 ¦safe¦  - ¦19¦ ¦vaccines¦ ¦for¦ 𐋇 ¦e ur op e ans¦
𐋇¦a¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦is¦ ¦our¦ ¦best¦ ¦ch ance¦ ¦to¦ ¦be at¦ ¦coronavirus¦ ¦and¦ ¦return¦ ¦to¦ ¦our¦ ¦normal¦ ¦lives¦ .
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦been¦ ¦working¦ ¦ti re le ss ly¦ ¦to¦ ¦sec ure¦ ¦doses¦ ¦of¦ ¦potential¦ ¦vaccines¦ ,▁ ¦that¦ ¦can¦ ¦be¦ ¦shared¦ ¦with¦ ¦all¦ .
¦4¦ 𐋇 ¦june¦ ¦2021¦ ▁–▁ 𐋇¦the¦  ¦pro po ses¦ ¦a¦ ¦stro ng¦ ¦mult il at eral¦ ¦tra de¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦
𐋇¦the¦  ¦has¦ ¦sub m itted¦ ¦its¦ ¦prop os al¦ ¦see king¦ ¦the¦ ¦co mm it ment¦ ¦of¦ 𐋇 ¦world¦ 𐋇 ¦tra de¦ 𐋇 ¦organization¦ ¦members¦ ¦for¦ ¦a¦ ¦mult il at eral¦ ¦tra de¦ ¦a ction¦ ¦plan¦ ¦to¦ ¦exp and¦ ¦the¦ ¦produc tion¦ ¦of¦  - ¦19¦ ¦vaccines¦ ¦and¦ ¦treatments¦ .
¦man¦ ¦h ol ding¦ ¦a¦ ¦lea f l et¦ 
¦21¦ 𐋇 ¦december¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦aut ho ri ses¦ ¦first¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦gr an ted¦ ¦a¦ ¦con di tional¦ ¦mar ke ting¦ ¦au th or isation¦ ¦for¦ ¦the¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦  ‑ ¦19¦ ¦developed¦ ¦by¦  ¦and¦ 𐋇 ¦pfizer¦ .
¦vaccine¦ 
¦17¦ 𐋇 ¦december¦ ¦2020¦ ▁–▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦an no un ces¦ 𐋇 ¦european¦ ¦vaccination¦ ¦days¦ ¦on¦ ¦27¦ ,▁ ¦28¦ ¦and¦ ¦29¦ 𐋇 ¦december¦
𐋇¦in¦ ¦case¦ ¦of¦ ¦a¦ ¦success ful¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦au th or isation¦ ¦by¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦medicines¦ 𐋇 ¦agency¦ ¦and¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ,▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦announced¦ ¦that¦ ¦on¦ ¦27¦ ,▁ ¦28¦ ¦and¦ ¦29¦ 𐋇 ¦december¦ ¦vaccination¦ ¦against¦ ¦the¦ ¦coronavirus¦ ¦will¦ ¦start¦ ¦across¦ ¦the¦  .
¦w om an¦ ¦in¦ ¦f ron t¦ ¦of¦  ¦commission¦ ¦building¦ ¦loo king¦ ¦at¦ ¦her¦ ¦s ma rt phone¦ 
¦14¦ 𐋇 ¦december¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦la un ches¦ 𐋇 ¦re¦ - ¦open¦  ¦mobile¦ ¦app¦ ¦with¦ ¦regular¦ ¦upd ates¦ ¦on¦ ¦coronavirus¦ ¦health¦ ,▁ ¦safety¦ ¦and¦ ¦travel¦ ¦measures¦ ¦across¦ 𐋇 ¦europe¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦launched¦ ¦the¦ ¦free¦ 𐋇 ¦re¦ - ¦open¦  ¦mobile¦ ¦app¦ ,▁ ¦providing¦ ¦comp re he nsive¦ ,▁ ¦up¦ - ¦to¦ - ¦date¦ ¦information¦ ¦on¦ ¦the¦ ¦health¦ ,▁ ¦safety¦ ¦and¦ ¦travel¦ ¦measures¦ ¦in¦ ¦all¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦and¦ 𐋇 ¦i ce land¦ ,▁ 𐋇¦l ie ch t ens te in¦ ,▁ 𐋇 ¦nor way¦ ¦and¦ 𐋇 ¦sw it z er land¦ .
𐋇 ¦european¦ ¦ dem oc r acy¦ ¦a ction¦ ¦plan¦ 
¦3¦ 𐋇 ¦december¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ 𐋇¦ dem oc r acy¦ 𐋇¦a ction¦ 𐋇 ¦plan¦ :▁ ¦making¦  ¦ dem oc r ac ies¦ ¦stro nger¦
𐋇¦the¦ ¦coronavirus¦ ¦pandemic¦ ¦has¦ ¦hi gh li gh ted¦ ¦challen ges¦ ¦to¦ ¦the¦  ¦ dem oc r ac ies¦ .
𐋇 ¦mask¦ ¦and¦  ¦f la g¦ 
¦2¦ 𐋇 ¦december¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦pres ents¦ ▁“ 𐋇 ¦staying¦ ¦safe¦ ¦from¦  - ¦19¦ ¦during¦ ¦w in ter¦ ” ▁ ¦strate gy¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦ad op ted¦ ¦a¦ ¦strate gy¦ ¦for¦ ¦sus ta in ably¦ ¦mana ging¦ ¦the¦ ¦pandemic¦ ¦over¦ ¦the¦ ¦coming¦ ¦w in ter¦ ¦months¦ ,▁ ¦when¦ ¦the¦ ¦virus¦ ¦transmission¦ ¦risk¦ ¦may¦ ¦increase¦ ¦ owing¦ ¦to¦ ¦indoor¦ ¦gatherings¦ .
𐋇¦the¦ ¦strate gy¦ ¦recommends¦ ¦continued¦ ¦v ig il ance¦ ¦and¦ ¦ca ution¦ ¦throughout¦ ¦the¦ ¦w in ter¦ ¦period¦ ¦and¦ ¦into¦ ¦2021¦ ¦when¦ ¦the¦ ¦r oll¦ ¦out¦ ¦of¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccines¦ ¦will¦ ¦occur¦ .
𐋇¦a¦ ¦coordin ated¦  - ¦w ide¦ ¦approa ch¦ ¦is¦ ¦key¦ ¦to¦ ¦avoid¦ ¦a¦ ¦res ur gence¦ ¦of¦ ¦the¦ ¦virus¦ ,▁ ¦and¦ ¦any¦ ¦re la x ation¦ ¦of¦ ¦measures¦ ¦should¦ ¦take¦ ¦into¦ ¦acco un t¦ ¦the¦ ¦evolution¦ ¦of¦ ¦the¦ ¦epidemiological¦ ¦situation¦ .
¦1¦ 𐋇 ¦december¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦dis b ur ses¦ ▁€ ¦8¦ . ¦5¦ ¦billion¦ ¦under¦  ¦to¦ ¦five¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦help¦ ¦sus tain¦ ¦jobs¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦dis b ur sed¦ ▁€ ¦8¦ .
𐋇 ¦pharm a¦ ¦strate gy¦ 
¦25¦ 𐋇 ¦november¦ ¦2020¦ ▁-▁ 𐋇 ¦pharm a ce ut ical¦ 𐋇 ¦strate gy¦ ¦for¦ 𐋇 ¦europe¦ :▁ ¦aff or d able¦ ,▁ ¦acc es sible¦ ¦and¦ ¦safe¦ ¦medicines¦ ¦for¦ ¦all¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦ad op ted¦ ¦a¦ 𐋇 ¦pharm a ce ut ical¦ 𐋇 ¦strate gy¦ ¦for¦ 𐋇 ¦europe¦ ¦to¦ ¦ensure¦ ¦that¦ ¦everyone¦ ¦will¦ ¦have¦ ¦access¦ ¦to¦ ¦in n ov ative¦ ¦and¦ ¦aff or d able¦ ¦medicines¦ ¦while¦ ¦supp or ting¦ ¦comp e ti ti ve ness¦ ,▁ ¦in n ov ation¦ ¦and¦ ¦s ust ai na bility¦ ¦of¦ ¦the¦  ’ ¦s¦ ¦pharm a ce ut ical¦ ¦indust ry¦ .
𐋇 ¦rapid¦ ¦tests¦ 
¦18¦ 𐋇 ¦november¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦steps¦ ¦up¦ ¦ actions¦ ¦on¦ ¦testing¦ ¦with¦ ¦a¦ ¦recommend ation¦ ¦on¦ ¦rapid¦ ¦anti gen¦ ¦tests¦ ¦and¦ ¦support¦ ¦to¦ ¦increase¦ ¦testing¦ ¦capacity¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦ad op ted¦ ¦a¦ ¦recommend ation¦ ¦on¦ ¦the¦ ¦use¦ ¦of¦ ¦rapid¦ ¦anti gen¦ ¦tests¦ ¦for¦ ¦the¦ ¦diagnosis¦ ¦of¦  - ¦19¦ ¦with¦ ¦the¦ ¦ai m¦ ¦of¦ ¦ ens u ring¦ ¦the¦ ¦free¦ ¦movement¦ ¦of¦ ¦people¦ ¦and¦ ¦the¦ ¦s m oo th¦ ¦func tion ing¦ ¦of¦ ¦the¦ ¦inter n al¦ ¦market¦ 
¦17¦ 𐋇 ¦november¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦dis b ur ses¦ ▁€ ¦14¦ ¦billion¦ ¦under¦  ¦to¦ ¦n ine¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦help¦ ¦sus tain¦ ¦jobs¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦dis b ur sed¦ ▁€ ¦14¦ ¦billion¦ ¦to¦ ¦n ine¦  ¦countries¦ ¦in¦ ¦the¦ ¦second¦ ¦inst al ment¦ ¦of¦ ¦fi na ncial¦ ¦support¦ ¦to¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦under¦ ¦the¦  ¦inst ru ment¦ .
𐋇 ¦european¦ 𐋇¦health¦ 𐋇 ¦union¦ 
¦11¦ 𐋇 ¦november¦ ¦2020¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦ta kes¦ ¦first¦ ¦steps¦ ¦towards¦ ¦building¦ ¦a¦ 𐋇 ¦european¦ 𐋇¦health¦ 𐋇 ¦union¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦is¦ ¦p ut ting¦ ¦for w ard¦ ¦a¦ ¦set¦ ¦of¦ ¦prop os als¦ ¦to¦ ¦strength en¦ ¦the¦  ' ¦s¦ ¦health¦ ¦sec urity¦ ¦fra me work¦ ,▁ ¦and¦ ¦to¦ ¦re in for ce¦ ¦the¦ ¦crisis¦ ¦preparedness¦ ¦and¦ ¦response¦ ¦role¦ ¦of¦ ¦key¦  ¦agencies¦ .
 
¦10¦ 𐋇 ¦november¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦w el c omes¦ ¦ag r ee ment¦ ¦on¦ ▁€ ¦1¦ . ¦8¦ ¦tri ll ion¦  ¦long¦ - ¦term¦ ¦b ud g et¦ ¦and¦  ¦to¦ ¦help¦ ¦bu i ld¦ ¦gr ee ner¦ ,▁ ¦more¦ ¦digital¦ ¦and¦ ¦more¦ ¦re si li ent¦ 𐋇 ¦europe¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ ¦and¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦in¦ ¦the¦ 𐋇 ¦cou nc il¦ ¦have¦ ¦a gre ed¦ ¦on¦ ¦the¦  ’ ¦s¦ ¦long¦ - ¦term¦ ¦b ud g et¦ ¦and¦  .
𐋇 ¦european¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ ¦figures¦ 
¦5¦ 𐋇 ¦november¦ ¦2020¦ ▁-▁ 𐋇 ¦aut um n¦ ¦2020¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦
𐋇¦the¦ ¦economic¦ ¦impact¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦diff ered¦ ¦widely¦ ¦across¦ ¦the¦  .
¦w om an¦ ¦h ol ding¦ ¦a¦ ¦phone¦ 
¦28¦ 𐋇 ¦o ct ob er¦ ▁–▁ 𐋇¦t ac k ling¦ ¦the¦ ¦coronavirus¦ ¦res ur gence¦ :▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦s ets¦ ¦out¦ ¦new¦ ¦ actions¦ ¦to¦ ¦re in for ce¦ ¦preparedness¦ ¦and¦ ¦response¦ ¦measures¦ ¦across¦ ¦the¦ 
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦set¦ ¦out¦ ¦conc r et e¦ ¦ actions¦ ¦in¦ ¦a¦ 𐋇 ¦commun ication¦ ¦on¦ ¦additional¦  - ¦19¦ ¦response¦ ¦measures¦ ¦to¦ ¦help¦ ¦limit¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ,▁ ¦sa ve¦ ¦lives¦ ¦and¦ ¦bu i ld¦ ¦increased¦ ¦re si li ence¦ ¦across¦ ¦several¦ ¦areas¦ ¦in¦ ¦all¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ .
𐋇 ¦first¦ ¦dis b ur se ments¦ ¦under¦  ¦fi na ncial¦ ¦support¦ 
¦27¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁-▁ 𐋇 ¦commission¦ ¦dis b ur ses¦ ¦a¦ ¦first¦ ▁€ ¦17¦ ¦billion¦  ¦inst al ments¦ ¦to¦ 𐋇 ¦italy¦ ,▁ 𐋇 ¦spain¦ ¦and¦ 𐋇 ¦po land¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦dis b ur sed¦ ¦a¦ ¦total¦ ¦of¦ ▁€ ¦17¦ ¦billion¦ ¦to¦ 𐋇 ¦italy¦ ▁( € ¦10¦ ¦billion¦ ),▁ 𐋇 ¦spain¦ ▁( € ¦6¦ ¦billion¦ )▁ ¦and¦ 𐋇 ¦po land¦ ▁( € ¦1¦ ¦billion¦ )▁ ¦in¦ ¦the¦ ¦first¦ ¦inst al ment¦ ¦of¦  ¦fi na ncial¦ ¦support¦ ¦to¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ .
¦man¦ ¦loo king¦ ¦at¦ ¦s ma rt phone¦ ¦in¦  
¦19¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁-▁  ¦inter op e ra bility¦ ¦ga te way¦ ¦go es¦ ¦live¦ ,▁ ¦first¦ ¦contact¦ ¦tracing¦ ¦and¦ ¦war ning¦ ¦app s¦ ¦linked¦ ¦to¦ ¦the¦  - ¦system¦
𐋇¦the¦ 𐋇 ¦commission¦ ,▁ ¦at¦ ¦the¦ ¦inv it ation¦ ¦by¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ,▁ ¦has¦ ¦set¦ ¦up¦ ¦an¦  - ¦w ide¦ ¦system¦ ¦to¦ ¦ensure¦ ¦that¦ ¦coronavirus¦ ¦contact¦ ¦and¦ ¦tracing¦ ¦app s¦ ¦can¦ ▁ ‘ ¦talk¦ ¦to¦ ¦each¦ ¦other¦ ’ .
𐋇¦a¦ ¦sc ie nt ist¦ ¦working¦ ¦at¦ ¦a¦ ¦scre en¦ 
¦15¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁–▁  ¦vaccine¦ ¦strate gy¦ :▁ ¦preparedness¦ ¦for¦  - ¦19¦ ¦vaccination¦ ¦strategies¦ ¦and¦ ¦vaccine¦ ¦dep lo yment¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦published¦ ¦a¦ 𐋇 ¦commun ication¦ ¦on¦ ¦preparedness¦ ¦for¦  - ¦19¦ ¦vaccination¦ ¦strategies¦ ¦and¦ ¦vaccine¦ ¦dep lo yment¦ .
¦two¦ ¦people¦ ¦with¦ ¦ lu gg age¦ ¦at¦ ¦the¦ ¦tra in¦ ¦st ation¦ 
¦13¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁–▁ 𐋇¦a gre e ment¦ ¦on¦ ¦a¦ ¦coordin ated¦ ¦approa ch¦ ¦to¦ ¦measures¦ ¦restricting¦ ¦free¦ ¦movement¦ ¦in¦ ¦the¦  ¦in¦ ¦v ie w¦ ¦of¦  - ¦19¦
 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦have¦ ¦a gre ed¦ ¦on¦ ¦a¦ ¦coordin ated¦ ¦approa ch¦ ¦to¦ ¦travel¦ ¦restrictions¦ ¦linked¦ ¦to¦ ¦the¦  - ¦19¦ ¦pandemic¦ .
𐋇¦more¦ ¦information¦
¦13¦ 𐋇 ¦billion¦ ¦f ig ure¦ ¦ ic on¦ ¦for¦  
¦12¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁–▁ 𐋇 ¦first¦ ¦results¦ ¦of¦ ¦the¦ ¦imple ment ation¦ ¦of¦ ¦the¦ 𐋇¦coronavirus¦ 𐋇 ¦response¦ 𐋇 ¦in ve st ment¦ 𐋇 ¦i ni ti at ives¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦released¦ ¦the¦ ¦provi si onal¦ ¦first¦ ¦results¦ ¦of¦ ¦the¦ 𐋇¦coronavirus¦ 𐋇 ¦response¦ 𐋇 ¦in ve st ment¦ 𐋇 ¦i ni ti at ives¦ :▁ ¦the¦  ¦mo bi li sed¦ ¦over¦ ▁€ ¦13¦ ¦billion¦ ¦to¦ ¦t ac k le¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ .
 - ¦19¦ 
¦8¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦app ro ves¦ ¦third¦ ¦contr ac t¦ ¦for¦ ¦potential¦  - ¦19¦ ¦vaccines¦ ¦and¦ ¦signs¦ 𐋇 ¦rem de si vir¦ ¦de al¦
𐋇¦on¦ ¦7¦ 𐋇 ¦o ct ob er¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦approved¦ ¦a¦ ¦third¦ ¦contr ac t¦ ¦with¦ ¦a¦ ¦pharm a ce ut ical¦ ¦compan y¦ ,▁ 𐋇 ¦j an ss en¦ 𐋇 ¦pharm a ce ut ic a¦  ,▁ ¦for¦ ¦vaccine¦ ¦doses¦ ¦for¦ ¦200¦ ¦million¦ ¦people¦ .
¦st ock¦ ¦numbers¦ 
¦7¦ 𐋇 ¦o ct ob er¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦to¦ ¦iss ue¦   ¦b on ds¦ ¦of¦ ¦up¦ ¦to¦ ▁€ ¦100¦ ¦billion¦ ¦as¦ ¦social¦ ¦b on ds¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦announced¦ ¦that¦ ¦it¦ ¦will¦ ¦iss ue¦   ¦social¦ ¦b on ds¦ ¦of¦ ¦up¦ ¦to¦ ▁€ ¦100¦ ¦billion¦ ¦and¦ ¦that¦ ¦it¦ ¦has¦ ¦ad op ted¦ ¦an¦ ¦inde p en de ntly¦ ¦e va lu ated¦ 𐋇¦social¦ 𐋇¦b on d¦ 𐋇 ¦fra me work¦ .
𐋇 ¦ru le¦ ¦of¦ ¦law¦ ¦report¦ 
¦30¦ 𐋇 ¦september¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦un ve il s¦ ¦first¦ - ¦e ver¦ ¦ru le¦ ¦of¦ ¦law¦ ¦report¦ :▁ ¦coronavirus¦ ¦emergency¦ ¦measures¦ ¦must¦ ¦resp ect¦  ’ ¦s¦ ¦fun d a mental¦ ¦pri nc ip les¦ ¦and¦ ¦val ues¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦pres ented¦ ¦its¦ ¦first¦  - ¦w ide¦ 𐋇 ¦ru le¦ ¦of¦ 𐋇 ¦law¦ 𐋇 ¦report¦ ,▁ ¦a¦ ¦new¦ ¦preven tive¦ ¦t oo l¦ ¦at¦ ¦the¦ ¦heart¦ ¦of¦ ¦the¦ ¦new¦ 𐋇 ¦european¦ 𐋇 ¦ru le¦ ¦of¦ 𐋇 ¦law¦ 𐋇 ¦mechan ism¦ .
𐋇¦s te ll a¦ 𐋇 ¦k y r ia k i des¦  ¦m eeting¦ 
¦24¦ 𐋇 ¦september¦ ¦2020¦ ▁-▁ 𐋇 ¦new¦  ¦risk¦ ¦assessment¦ ¦calls¦ ¦for¦ ¦str ic ter¦ ¦measures¦ ¦due¦ ¦to¦ ¦increased¦ ¦infection¦ ¦rates¦
𐋇¦the¦  ¦has¦ ¦its¦ ¦upd ated¦ ¦rapid¦ ¦risk¦ ¦assessment¦ ¦on¦ ¦the¦ ¦development¦ ¦of¦ ¦the¦ ¦epidemiological¦ ¦situation¦ ¦and¦ ¦f in ds¦ ¦that¦ ¦infection¦ ¦rates¦ ¦have¦ ¦increased¦ ¦across¦ ¦the¦  ¦and¦ ¦the¦  .
𐋇¦an¦ ¦employe e¦ ¦is¦ ¦contro lling¦ ¦a¦ ¦ma ch ine¦ ¦in¦ ¦a¦ ¦fact ory¦ 
¦22¦ 𐋇 ¦september¦ ¦2020¦ ▁-▁ 𐋇 ¦commission¦ ¦w el c omes¦ ¦f in al isation¦ ¦of¦ ¦gu ar an te e¦ ¦system¦ ¦for¦ ▁€ ¦100¦ ¦billion¦  ¦inst ru ment¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦w el c omes¦ ¦the¦ ¦act iv ation¦ ¦of¦ ¦the¦  ▁-▁ ¦the¦ ¦temporary¦ 𐋇 ¦support¦ ¦m it ig ating¦ 𐋇 ¦une mp lo yment¦ 𐋇¦r is ks¦ ¦in¦ 𐋇 ¦emergency¦ ¦inst ru ment¦ ,▁ ¦which¦ ¦will¦ ¦provide¦ ¦up¦ ¦to¦ ▁€ ¦100¦ ¦billion¦ ¦in¦ ¦fi na ncial¦ ¦support¦ ¦to¦ ¦help¦ ¦protect¦ ¦workers¦ ¦and¦ ¦jobs¦ ¦affected¦ ¦by¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ .
𐋇 ¦next¦ 𐋇 ¦gener ation¦  
¦17¦ 𐋇 ¦september¦ ¦2020¦ ▁-▁ 𐋇¦the¦ 𐋇 ¦commission¦ ¦pres ents¦ ¦next¦ ¦steps¦ ¦for¦ ▁€ ¦6 7 2¦ . ¦5¦ ¦billion¦ 𐋇 ¦recovery¦ ¦and¦ 𐋇 ¦re si li ence¦ 𐋇 ¦facility¦ ¦in¦ ¦2021¦ 𐋇 ¦ann ual¦ 𐋇 ¦sus ta in able¦ 𐋇 ¦gr ow th¦ 𐋇 ¦strate gy¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦set¦ ¦out¦ ¦gu id ance¦ ¦for¦ ¦the¦ ¦imple ment ation¦ ¦of¦ ¦the¦ 𐋇 ¦recovery¦ ¦and¦ 𐋇 ¦re si li ence¦ 𐋇 ¦facility¦ ¦in¦ ¦its¦ ¦2021¦ 𐋇 ¦ann ual¦ 𐋇 ¦sus ta in able¦ 𐋇 ¦gr ow th¦ 𐋇 ¦strate gy¦ .
𐋇 ¦two¦ ¦sc ie nt ists¦ ¦working¦ ¦in¦ ¦a¦ ¦la b¦ 
¦10¦ 𐋇 ¦september¦ ¦2020¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦and¦ ¦the¦ 𐋇 ¦world¦ 𐋇¦health¦ 𐋇 ¦organ isation¦ ¦to¦ ¦strength en¦ ¦coronavirus¦ ¦treatments¦ ¦in¦ ¦global¦ ¦coll a bor ation¦
𐋇 ¦today¦ ,▁ ¦the¦ 𐋇 ¦president¦ ¦of¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ,▁ 𐋇 ¦u rs ul a¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ,▁ ¦and¦ ¦the¦ 𐋇 ¦director¦ 𐋇 ¦general¦ ¦of¦ ¦the¦  ,▁ 𐋇¦t ed ro s¦ 𐋇¦ad h an om¦ 𐋇¦g he b re y es us¦ ,▁ ¦launched¦ ¦and¦ ¦c o¦ - ¦h os ted¦ ¦the¦ ¦first¦ ¦m eeting¦ ¦of¦ ¦the¦ 𐋇 ¦high¦ 𐋇 ¦level¦ 𐋇 ¦facilit ation¦ 𐋇 ¦cou nc il¦ ¦to¦ ¦sp e ed¦ ¦up¦ ¦the¦ ¦development¦ ¦and¦ ¦dep lo yment¦ ¦of¦ ¦vaccines¦ ,▁ ¦tests¦ ¦and¦ ¦treatments¦ ¦against¦  - ¦19¦ .
¦vaccines¦ 
¦9¦ 𐋇 ¦september¦ ¦2020¦ ▁–▁ 𐋇 ¦commission¦ ¦ad ds¦ ¦to¦ ¦vaccines¦ ¦port f o li o¦ ¦following¦ ¦t al ks¦ ¦with¦  - 𐋇 ¦pfizer¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦conc luded¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ ¦a¦ ¦si x th¦ ¦manufact ur er¦ ¦for¦ ¦the¦ ¦potential¦ ¦pur ch ase¦ ¦of¦ ¦a¦ ¦vaccine¦ ¦against¦  - ¦19¦ .
¦trave l er¦ ¦at¦ ¦the¦ ¦tra in¦ ¦st ation¦ 
¦4¦ 𐋇 ¦september¦ ¦2020¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦har mon ise¦ ¦national¦ ¦measures¦ ¦affecting¦ ¦free¦ ¦movement¦ ¦in¦ ¦the¦ 
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦ad op ted¦ ¦a¦ ¦prop os al¦ ¦for¦ ¦a¦ 𐋇 ¦cou nc il¦ 𐋇 ¦recommend ation¦ ¦to¦ ¦improve¦ ¦the¦ ¦coordin ation¦ ¦and¦ ¦commun ication¦ ¦of¦ ¦measures¦ ¦that¦ ¦restrict¦ ¦free¦ ¦movement¦ ¦due¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ .
¦27¦ 𐋇 ¦april¦ ¦2021¦ ▁-▁  ¦ chan n els¦ ¦critical¦ ¦support¦ ¦to¦ 𐋇 ¦india¦ ¦via¦  𐋇 ¦civ il¦ 𐋇 ¦protection¦ 𐋇 ¦mechan ism¦
𐋇¦a¦ ¦sh ip ment¦ ¦of¦ ¦ur ge ntly¦ ¦needed¦ ¦oxygen¦ ,▁ ¦medic ine¦ ¦and¦ ¦equipment¦ ¦will¦ ¦be¦ ¦del iv ered¦ ¦over¦ ¦the¦ ¦coming¦ ¦days¦ ¦by¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ 𐋇 ¦india¦ ,▁ ¦following¦ ¦the¦ ¦country¦ ' ¦s¦ ¦requ est¦ ¦for¦ ¦support¦ .
𐋇¦b er la y mon t¦ 
¦16¦ 𐋇 ¦april¦ ¦2021¦ ▁- ▁€ ¦5 6 2¦ . ¦5¦ ¦million¦ ¦in¦  -  ¦in ve st ment¦ ¦fun ding¦ ¦all oc ated¦ ¦to¦ 𐋇¦b ul g ar ia¦ ,▁ 𐋇¦f in land¦ ,▁ 𐋇 ¦france¦ ¦and¦ 𐋇¦li th u a nia¦
 -  ¦in ve st ments¦ ¦of¦ ¦around¦ ▁€ ¦5 6 2¦ .
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ 
¦14¦ 𐋇 ¦april¦ ¦2021¦ ▁-▁ ¦100¦ ¦million¦ ¦vaccin ations¦ ¦against¦  - ¦19¦ ¦in¦ ¦the¦ 
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ : ▁“ 𐋇 ¦vaccination¦ ¦is¦ ¦p ic king¦ ¦up¦ ¦sp e ed¦ ¦across¦ 𐋇 ¦europe¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦have¦ ¦received¦ ¦over¦ ¦12 6¦ ¦million¦ ¦doses¦ ¦of¦ ¦vaccines¦ ¦as¦ ¦of¦ ¦y es ter day¦ .
𐋇 ¦pi ct ure¦ ¦of¦ ¦the¦ 𐋇¦b er la y mon t¦ ¦fac a de¦ 
¦14¦ 𐋇 ¦april¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦gets¦ ¦rea dy¦ ¦to¦ ¦ra ise¦ ¦up¦ ¦to¦ ▁€ ¦8 00¦ ¦billion¦ ¦under¦  ¦to¦ ¦fun d¦ ¦the¦ ¦recovery¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦taken¦ ¦steps¦ ¦to¦ ¦ensure¦ ¦that¦ ¦bor r owing¦ ¦under¦ ¦the¦ ¦temporary¦ ¦recovery¦ ¦inst ru ment¦  ¦will¦ ¦be¦ ¦fi na nced¦ ¦on¦ ¦the¦ ¦most¦ ¦adv an ta ge ous¦ ¦terms¦ ¦for¦  ¦countries¦ ¦and¦ ¦their¦ ¦citizens¦ .
𐋇 ¦hu ma ni ta ri an¦ ¦aid¦ ¦workers¦ ¦in¦ ¦a¦ ¦wa re h ou se¦ 
¦8¦ 𐋇 ¦april¦ ¦2021¦ ▁-▁ 𐋇 ¦team¦ 𐋇 ¦europe¦ ¦continu es¦ ¦to¦ ¦support¦ ¦part ner¦ ¦countries¦ ¦with¦ ¦more¦ ¦than¦ ▁€ ¦26¦ ¦billion¦ ¦dis b ur sed¦ ¦in¦ ¦one¦ ¦year¦
𐋇¦by¦ ¦1¦ 𐋇 ¦january¦ ¦2021¦ ,▁ 𐋇 ¦team¦ 𐋇 ¦europe¦ ¦had¦ ¦already¦ ¦supp or ted¦ ¦over¦ ¦1 3 0¦ ¦part ner¦ ¦countries¦ ¦around¦ ¦the¦ ¦world¦ ¦with¦ ¦over¦ ▁€ ¦26¦ ¦billion¦ 
¦7¦ 𐋇 ¦april¦ ¦2021¦ ▁-▁ 𐋇 ¦global¦ 𐋇¦health¦ 𐋇 ¦summ it¦ :▁ 𐋇¦stay¦ ¦up¦ ¦to¦ ¦date¦ ¦via¦ ¦the¦ ¦new¦ ¦we b s ite¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦published¦ ¦a¦ ¦new¦ ¦we b s ite¦ ¦with¦ ¦key¦ ¦information¦ ¦about¦ ¦the¦ ¦up co ming¦ 𐋇 ¦global¦ 𐋇¦health¦ 𐋇 ¦summ it¦ .
𐋇¦ im age¦ ¦of¦ ¦the¦ 𐋇¦b er la y mon t¦ ¦ban ner¦ ▁" 𐋇 ¦next¦ 𐋇 ¦gener ation¦  
¦6¦ 𐋇 ¦april¦ ¦2021¦ ▁–▁ 𐋇 ¦first¦  -  ¦support¦ ¦measures¦ ¦for¦ ¦recovery¦ ¦and¦ ¦trans ition¦ ¦approved¦ ¦for¦ ¦the¦ 𐋇¦ne ther lands¦ ¦and¦ 𐋇 ¦au str ia¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦approved¦ ¦the¦ ¦first¦ ¦deci sions¦ ¦under¦  -  ¦invol ving¦ ¦mod if ications¦ ¦of¦ ¦four¦ ¦oper a tional¦ ¦programmes¦ ¦for¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦regi onal¦ 𐋇 ¦development¦ 𐋇 ¦fun d¦ ¦in¦ ¦the¦ 𐋇¦ne ther lands¦ ¦and¦ 𐋇 ¦au str ia¦ ¦that¦ ¦will¦ ¦increase¦ ¦the¦ ¦fun ding¦ ¦available¦ ¦for¦ ¦in ve st ments¦ ¦by¦ ¦nearly¦ ▁€ ¦26 2¦ ¦million¦ ¦from¦  -  .
¦worker¦ ¦in¦ ¦a¦ ¦sho p¦ 
¦30¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦dis b ur ses¦ ¦further¦ ▁€ ¦13¦ ¦billion¦ ¦under¦  ¦to¦ ¦6¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦protect¦ ¦workers¦ ¦and¦ ¦jobs¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦dis b ur sed¦ ▁€ ¦13¦ ¦billion¦ ¦to¦ ¦six¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦in¦ ¦the¦ ¦si x th¦ ¦inst al ment¦ ¦of¦ ¦fi na ncial¦ ¦support¦ ¦under¦ ¦the¦  ¦inst ru ment¦ ¦to¦ ¦protect¦ ¦jobs¦ ¦and¦ ¦workers¦ .
𐋇¦a¦ ¦nur se¦
¦26¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ € ¦5¦ . ¦1¦ ¦billion¦  ¦ent ers¦ ¦into¦ ¦for ce¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦w el co med¦ ¦the¦  ¦programme¦ ¦entering¦ ¦into¦ ¦for ce¦ .
𐋇¦l ot¦ ¦of¦ ¦vaccines¦ ¦doses¦ 
¦24¦ 𐋇 ¦march¦ ¦2021¦ ▁-▁ 𐋇 ¦commission¦ ¦strength ens¦ ¦trans pa re ncy¦ ¦and¦ ¦au th or isation¦ ¦mechan ism¦ ¦for¦ ¦exp orts¦ ¦of¦ ¦vaccines¦ ¦against¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦introduced¦ ¦additional¦ ¦pri nc ip les¦ ¦for¦ ¦cons id er ation¦ ¦before¦ ¦au th or ising¦ ¦exp orts¦ ¦of¦ ¦vaccines¦ :▁ ¦rec i pr oc ity¦ ¦and¦ ¦prop or tion ality¦ .
𐋇¦a¦ ¦man¦ ¦sup erv ising¦ ¦a¦ ¦young¦ ¦employer¦ 
¦22¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇 ¦report¦ ¦confir ms¦  ' ¦s¦ ¦success ¦ ¦in¦ ¦protecting¦ ¦jobs¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦published¦ ¦its¦ ¦first¦ ¦preliminary¦ ¦assessment¦ ¦of¦  ,▁ ¦the¦ ▁€ ¦100¦ ¦billion¦ ¦inst ru ment¦ ¦d ed ic ated¦ ¦to¦ ¦protecting¦ ¦jobs¦ ¦and¦ ¦econom ies¦ ¦from¦ ¦the¦ ¦effects¦ ¦of¦ ¦the¦  - ¦19¦ ¦pandemic¦ .
𐋇¦a¦ ¦g ir l¦ ¦waiting¦ ¦in¦ ¦line¦ ¦at¦ ¦the¦ ¦air p ort¦ 
¦17¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦a¦ 𐋇 ¦digital¦ 𐋇¦ gre en¦ 𐋇 ¦certificate¦ ¦with¦ ¦information¦ ¦about¦ ¦vaccination¦ ,▁ ¦tests¦ ¦and¦ ¦recovery¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦establis h¦ ¦an¦  - ¦w ide¦ ¦fra me work¦ ¦on¦ ¦a¦ 𐋇 ¦digital¦ 𐋇¦ gre en¦ 𐋇 ¦certificate¦ ¦for¦ ¦the¦ ¦iss u ance¦ ,▁ ¦ ver ification¦ ¦and¦ ¦ac cept ance¦ ¦of¦ ¦vaccination¦ ,▁ ¦testing¦ ¦and¦ ¦recovery¦ ¦ce rt ific ates¦ .
𐋇 ¦two¦ ¦people¦ ¦t alking¦ 
¦16¦ 𐋇 ¦march¦ ¦2021¦ ▁-▁ 𐋇 ¦commission¦ ¦dis b ur ses¦ ¦further¦ ▁€ ¦9¦ ¦billion¦ ¦under¦  ¦to¦ ¦7¦  𐋇 ¦me mber¦ 𐋇 ¦states¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦dis b ur sed¦ ▁€ ¦9¦ ¦billion¦ ¦to¦ ¦7¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦in¦ ¦a¦ ¦f if th¦ ¦inst al ment¦ ¦under¦ ¦the¦  ¦inst ru ment¦ .
¦vaccine¦ ¦vi als¦ 
¦11¦ 𐋇 ¦march¦ ¦2021¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦aut ho ri ses¦ ¦f our th¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦gr an ted¦ ¦a¦ ¦con di tional¦ ¦mar ke ting¦ ¦au th or isation¦ ¦for¦ ¦the¦ ¦vaccine¦ ¦against¦  - ¦19¦ ¦developed¦ ¦by¦ 𐋇 ¦johnson¦ ▁&▁ 𐋇 ¦johnson¦ ,▁ ¦making¦ ¦it¦ ¦the¦ ¦f our th¦ ¦vaccine¦ ¦aut ho ri sed¦ ¦in¦ ¦the¦  .
𐋇¦a¦ ¦nur se¦ 
¦11¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦use¦ ▁€ ¦5 3 0¦ ¦million¦ ¦under¦ ¦the¦  𐋇 ¦solidarity¦ ¦fun d¦ ¦to¦ ¦fight¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦is¦ ¦p ut ting¦ ¦for w ard¦ ¦a¦ ¦pac k age¦ ¦of¦ ¦almost¦ ▁€ ¦5 3 0¦ ¦million¦ ¦in¦ ¦fi na ncial¦ ¦support¦ ¦under¦ ¦the¦  𐋇 ¦solidarity¦ 𐋇 ¦fun d¦ ¦to¦ ¦support¦ ¦public¦ ¦exp end it ure¦ ¦on¦ ¦medical¦ ¦and¦ ¦personal¦ ¦protective¦ ¦equipment¦ ,▁ ¦emergency¦ ¦support¦ ¦to¦ ¦the¦ ¦population¦ ,▁ ¦and¦ ¦measures¦ ¦to¦ ¦prevent¦ ,▁ ¦monitor¦ ¦and¦ ¦control¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦c arg o¦ ¦fre ight¦ ¦on¦ ¦p al et tes¦ ¦b ra nded¦ ¦with¦  ¦f la g¦ ¦being¦ ¦lo a ded¦ ¦o nt o¦ ¦an¦ ¦air p la ne¦ 
¦10¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇 ¦new¦ ¦a ction¦ ¦for¦  ' ¦s¦ ¦global¦ ¦aid¦ ¦delivery¦ ¦challen ged¦ ¦by¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦pres ented¦ ¦a¦ 𐋇 ¦commun ication¦ ¦on¦ ¦hu ma ni ta ri an¦ ¦a ction¦ ,▁ ¦s et ting¦ ¦out¦ ¦how¦ ¦the¦  ¦can¦ ¦step¦ ¦up¦ ¦and¦ ¦meet¦ ¦hu ma ni ta ri an¦ ¦challen ges¦ ¦br ought¦ ¦on¦ ¦by¦ ¦the¦  - ¦19¦ ¦pandemic¦ 
¦4¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇¦ ens u ring¦ ¦a¦ ¦jo b¦ - ¦ri ch¦ ¦recovery¦ :▁ 𐋇¦a ction¦ ¦plan¦ ¦on¦ ¦the¦ 𐋇 ¦european¦ ¦of¦ 𐋇¦social¦ 𐋇 ¦ri ghts¦ ¦s ets¦ ¦out¦ ¦effective¦ ¦support¦ ¦to¦ ¦employ ment¦
𐋇¦as¦ ¦part¦ ¦of¦ ¦the¦ 𐋇¦a ction¦ 𐋇 ¦plan¦ ¦on¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦pi ll ar¦ ¦of¦ 𐋇¦social¦ 𐋇 ¦ri ghts¦ ,▁ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pres ented¦ ¦a¦ 𐋇 ¦recommend ation¦ ¦for¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦e ase¦ ¦the¦ ¦trans ition¦ ¦from¦ ¦crisis¦ - ¦jo b¦ - ¦support¦ ¦to¦ ¦cre ating¦ ¦future¦ - ¦pr oo f¦ ¦jobs¦ :▁ 𐋇 ¦effective¦ 𐋇 ¦active¦ 𐋇 ¦support¦ ¦to¦ 𐋇 ¦employ ment¦ ▁(  
¦3¦ 𐋇 ¦march¦ ¦2021¦ ▁–▁ 𐋇¦one¦ ¦year¦ ¦since¦ ¦the¦ ¦outbreak¦ ¦of¦  - ¦19¦ :▁ ¦upd ated¦ ¦f is c al¦ ¦policy¦ ¦response¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦ad op ted¦ ¦a¦ 𐋇 ¦commun ication¦ ¦providing¦ 𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦with¦ ¦bro ad¦ ¦gu id ance¦ ¦on¦ ¦the¦ ¦co nd uc t¦ ¦of¦ ¦f is c al¦ ¦policy¦ ¦in¦ ¦the¦ ¦period¦ ¦ahead¦ ¦and¦ ¦s et ting¦ ¦out¦ ¦the¦ 𐋇 ¦commission¦ ' ¦s¦ ¦cons id er ations¦ ¦regarding¦ ¦the¦ ¦d ea ct iv ation¦ ¦or¦ ¦continued¦ ¦act iv ation¦ ¦of¦ ¦the¦ ¦general¦ ¦ es c ap e¦ ¦c la u se¦ .
𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ 
¦24¦ 𐋇 ¦february¦ ¦2021¦ ▁-▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦s po ke¦ ¦at¦ ¦the¦ 𐋇 ¦global¦ 𐋇¦c it iz en¦ 𐋇 ¦cam pa ig n¦ ¦la un ch¦ ¦event¦ ▁ ‘ 𐋇¦a¦ 𐋇 ¦recovery¦ 𐋇 ¦plan¦ ¦for¦ ¦the¦ 𐋇 ¦world¦ '
𐋇¦at¦ ¦the¦ ¦la un ch¦ ¦even¦ ¦of¦ ¦the¦ 𐋇 ¦global¦ 𐋇¦c it iz en¦ 𐋇 ¦cam pa ig n¦ ,▁ 𐋇 ¦president¦ ¦v on¦ ¦ der¦ 𐋇 ¦le y en¦ ¦said¦ :▁ 𐋇 ¦let¦ ¦us¦ ¦over come¦ ¦the¦ ¦pandemic¦ ¦with¦ ¦a¦ ¦global¦ ¦vaccination¦ ¦cam pa ig n¦ .
¦19¦ 𐋇 ¦february¦ ¦2021¦ ▁-▁  ¦do ub les¦ ¦cont rib ution¦ ¦to¦  ¦to¦ ▁€ ¦1¦ ¦billion¦ ¦to¦ ¦ensure¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccines¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦union¦ ¦announced¦ ¦an¦ ¦additional¦ ▁€ ¦500¦ ¦million¦ ¦for¦ ¦the¦  𐋇 ¦facility¦ ,▁ ¦do ub ling¦ ¦its¦ ¦cont rib ution¦ ¦to¦ ¦date¦ ¦for¦ ¦the¦ ¦global¦ ¦i ni ti ative¦ ¦sec ure¦ ¦f air¦ ¦and¦ ¦e qu it able¦ ¦access¦ ¦to¦ ¦safe¦ ¦and¦ ¦effective¦  - ¦19¦ ¦vaccines¦ .
¦17¦ 𐋇 ¦february¦ ¦2021¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦t ac k les¦  - ¦19¦ ¦vari a nts¦ ¦while¦ ¦increasing¦ ¦preparedness¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦will¦ ¦establis h¦ ¦a¦ ¦new¦ ¦bi o¦ - ¦def ence¦ ¦plan¦ ¦called¦  𐋇 ¦inc ub ator¦ ¦to¦ ¦t ac k le¦ ¦short¦ ¦to¦ ¦me di um¦ - ¦term¦ ¦th rea ts¦ ¦and¦ ¦s im ul ta ne o usly¦ ¦prepare¦ ¦for¦ ¦the¦ ¦future¦ ¦by¦ ¦ser ving¦ ¦as¦ ¦the¦ ¦b lu e pr int¦ ¦for¦ ¦the¦  ’ ¦s¦ ¦long¦ ¦term¦ ¦preparedness¦ ¦for¦ ¦health¦ ¦emer ge nc ies¦ 
¦11¦ 𐋇 ¦february¦ ¦2021¦ ▁–▁ 𐋇¦w in ter¦ ¦2021¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ ¦published¦ :▁ ¦a¦ ¦challen ging¦ ¦w in ter¦ ,▁ ¦but¦ ¦light¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦the¦ ¦t un n el¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦has¦ ¦published¦ ¦its¦ 𐋇¦w in ter¦ ¦2021¦ 𐋇 ¦economic¦ 𐋇 ¦for ec ast¦ ,▁ ¦which¦ ¦proj ects¦ ¦that¦ ¦the¦ ¦e ur o¦ ¦area¦ ¦econom y¦ ¦will¦ ¦gr ow¦ ¦by¦ ¦3¦ .
𐋇¦ im age¦ ¦of¦ ¦the¦ 𐋇¦b er la y mon t¦ ¦ban ner¦ ▁" 𐋇 ¦next¦ 𐋇 ¦gener ation¦  
¦10¦ 𐋇 ¦february¦ ¦2021¦ ▁–▁ € ¦6 7 2¦ . ¦5¦ ¦billion¦ 𐋇 ¦recovery¦ ¦and¦ 𐋇 ¦re si li ence¦ 𐋇 ¦facility¦ ¦to¦ ¦help¦ ¦me mber¦ ¦states¦ ¦emer ge¦ ¦stro nger¦ ¦from¦ ¦the¦ ¦crisis¦ ¦approved¦ ¦by¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦
𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦w el c omes¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦par l ia ment¦ ' ¦s¦ ¦v ot e¦ ¦confir ming¦ ¦the¦ ¦political¦ ¦ag r ee ment¦ ¦reached¦ ¦on¦ ¦the¦ 𐋇 ¦recovery¦ ¦and¦ 𐋇 ¦re si li ence¦ 𐋇 ¦facility¦ ¦of¦ 𐋇 ¦december¦ ¦2020¦ .
𐋇¦a st ra 𐋇 z en ec a¦ 
¦29¦ 𐋇 ¦january¦ ¦2021¦ ▁–▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦aut ho ri ses¦ ¦third¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦gr an ted¦ ¦a¦ ¦con di tional¦ ¦mar ke ting¦ ¦au th or isation¦ ¦for¦ ¦the¦ ¦vaccine¦ ¦against¦  - ¦19¦ ¦developed¦ ¦by¦ 𐋇¦a st ra 𐋇 z en ec a¦ ,▁ ¦making¦ ¦it¦ ¦the¦ ¦third¦ ¦vaccine¦ ¦aut ho ri sed¦ ¦in¦ ¦the¦  .
¦pr oo f¦ ¦of¦  - ¦19¦ ¦vaccination¦ 
¦27¦ 𐋇 ¦january¦ ¦2021¦ ▁–▁  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦ad op t¦ ¦guidelines¦ ¦on¦ ¦pr oo f¦ ¦of¦  - ¦19¦ ¦vaccination¦ ¦for¦ ¦medical¦ ¦pur po ses¦
𐋇¦the¦  𐋇 ¦members¦ 𐋇 ¦states¦ ,▁ ¦with¦ ¦the¦ ¦support¦ ¦of¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ,▁ ¦ad op ted¦ ¦guidelines¦ ¦on¦ ¦pr oo f¦ ¦of¦  - ¦19¦ ¦vaccination¦ ¦for¦ ¦medical¦ ¦pur po ses¦ .
𐋇¦people¦ ¦w alking¦ ¦in¦ ¦an¦ ¦air p ort¦ 
¦25¦ 𐋇 ¦january¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦update¦ ¦the¦ ¦coordin ated¦ ¦approa ch¦ ¦on¦ ¦free¦ ¦movement¦ ¦inside¦ ¦the¦  ,▁ ¦and¦ ¦travel¦ ¦from¦ ¦third¦ ¦countries¦ ¦to¦ ¦the¦ 
𐋇¦the¦ 𐋇 ¦commission¦ ¦is¦ ¦prop os ing¦ ¦additional¦ ¦sa fe g u ards¦ ¦and¦ ¦requ i re ments¦ ¦for¦ ¦international¦ ¦travellers¦ ¦into¦ ¦the¦  ,▁ ¦and¦ ¦to¦ ¦update¦ ¦the¦ 𐋇 ¦cou nc il¦ 𐋇 ¦recommend ation¦ ¦on¦ ¦coordin ated¦ ¦measures¦ ¦affecting¦ ¦free¦ ¦movement¦ ¦within¦ ¦the¦  .
¦vaccines¦ 
¦21¦ 𐋇 ¦january¦ ¦2021¦ ▁-▁  ¦lea ders¦ ¦a gre ed¦ ¦on¦ ¦sp eeding¦ ¦up¦ ¦vaccination¦ ¦and¦ ¦discus sed¦ ¦other¦ ¦measures¦ ¦at¦ 𐋇 ¦european¦ 𐋇 ¦cou nc il¦
𐋇¦at¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦cou nc il¦ ¦m eeting¦ ,▁ ¦lea ders¦ ¦no ted¦ ¦the¦ ¦s erio us ness¦ ¦of¦ ¦the¦ ¦situation¦ ¦in¦ ¦the¦ ¦light¦ ¦of¦ ¦the¦ ¦new¦ ¦vari a nts¦ .
¦person¦ ¦being¦ ¦vaccinated¦ 
¦19¦ 𐋇 ¦january¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦s ets¦ ¦out¦ ¦key¦ ¦ actions¦ ¦for¦ ¦a¦ ¦united¦ ¦f ron t¦ ¦to¦ ¦be at¦  - ¦19¦
𐋇 ¦two¦ ¦days¦ ¦ahead¦ ¦of¦ 𐋇 ¦european¦ 𐋇 ¦lea ders¦ ’ ▁ ¦v ide oc on fer ence¦ ¦on¦ ¦a¦ ¦coordin ate¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ,▁ ¦the¦ 𐋇 ¦commission¦ ¦set¦ ¦out¦ ¦ actions¦ ¦in¦ ¦a¦ 𐋇 ¦commun ication¦ ¦to¦ ¦step¦ ¦up¦ ¦the¦ ¦fight¦ ¦against¦ ¦the¦ ¦pandemic¦ ¦and¦ ¦sp e ed¦ ¦up¦ ¦vaccination¦ .
¦g ir l¦ ¦getting¦ ¦vaccinated¦ 
¦12¦ 𐋇 ¦january¦ ¦2021¦ ▁–▁ 𐋇¦the¦ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦conc lu des¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ 𐋇 ¦val ne v a¦ ¦to¦ ¦sec ure¦ ¦a¦ ¦new¦ ¦potential¦ ¦vaccine¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦conc luded¦ ¦ex pl or atory¦ ¦t al ks¦ ¦with¦ ¦the¦ ¦pharm a ce ut ical¦ ¦compan y¦ 𐋇 ¦val ne v a¦ ¦with¦ ¦a¦ ¦v ie w¦ ¦to¦ ¦pur ch as ing¦ ¦its¦ ¦potential¦ ¦vaccine¦ ¦against¦  - ¦19¦ ¦once¦ ¦pr ov en¦ ¦safe¦ ¦and¦ ¦effective¦ .
¦pfizer¦ ¦vaccine¦ 
¦8¦ 𐋇 ¦january¦ ¦2021¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦pro po ses¦ ¦to¦ ¦pur ch ase¦ ¦up¦ ¦to¦ ¦300¦ ¦million¦ ¦additional¦ ¦doses¦ ¦of¦  - 𐋇 ¦pfizer¦ ¦vaccine¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦prop osed¦ ¦to¦  𐋇 ¦me mber¦ 𐋇 ¦states¦ ¦to¦ ¦pur ch ase¦ ¦an¦ ¦additional¦ ¦200¦ ¦million¦ ¦doses¦ ¦of¦ ¦the¦  ¦and¦ 𐋇 ¦pfizer¦  - ¦19¦ ¦vaccine¦ ,▁ ¦with¦ ¦the¦ ¦o ption¦ ¦of¦ ¦ac qu i ring¦ ¦another¦ ¦100¦ ¦million¦ ¦doses¦ .
¦vaccination¦ ¦medical¦ ¦student¦ 
¦6¦ 𐋇 ¦january¦ ¦2021¦ ▁-▁ 𐋇 ¦european¦ 𐋇 ¦commission¦ ¦aut ho ri ses¦ ¦second¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦  - ¦19¦
𐋇¦the¦ 𐋇 ¦commission¦ ¦has¦ ¦gr an ted¦ ¦a¦ ¦con di tional¦ ¦mar ke ting¦ ¦au th or isation¦ ¦for¦ ¦the¦ ¦vaccine¦ ¦against¦  - ¦19¦ ¦developed¦ ¦by¦ 𐋇 ¦moderna¦ ,▁ ¦the¦ ¦second¦ ¦vaccine¦ ¦aut ho ri sed¦ ¦in¦ ¦the¦  .
𐋇 ¦vaccination¦ ¦prot ects¦ ¦people¦ ¦against¦ ¦serious¦ ¦and¦ ¦life¦ - ¦thre at ening¦ ¦infectious¦ ¦diseases¦ ,▁ ¦such¦ ¦as¦ ¦influenza¦ ▁( ¦flu¦ ),▁ ¦di ph ther ia¦ ,▁ ¦t et an us¦ ,▁ ¦pe rt us sis¦ ▁( ¦wh oo ping¦ ¦cough¦ ),▁ ¦meas les¦ ,▁ ¦m um ps¦ ,▁ ¦r ub e ll a¦ ▁( 𐋇¦g erm an¦ ¦meas les¦ ),▁ ¦me ni ng oc oc c al¦ ¦disease¦ ,▁ ¦inv as ive¦ ¦p ne um oc oc c al¦ ¦disease¦ ¦and¦ ¦po li o¦ .
𐋇 ¦each¦ ¦year¦ ,▁ ¦vaccination¦ ¦sto ps¦ ¦2¦ .
𐋇¦in¦ ¦the¦ ¦p ast¦ ,▁ ¦many¦ ¦people¦ ¦died¦ ¦of¦ ¦diseases¦ ¦that¦ ¦can¦ ¦now¦ ¦be¦ ¦preven ted¦ ¦through¦ ¦vaccination¦ .
𐋇 ¦meas les¦
¦12¦ - ¦18¦ ¦people¦ ▁
𐋇¦the¦ ¦centre¦ ¦d ot¦ ¦re pr es ent¦ ¦one¦ ¦person¦ ¦affected¦ ¦by¦ ¦a¦ ¦disease¦ .
𐋇 ¦vaccination¦ ¦helps¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦disease¦ ¦in¦ ¦communities¦ .
𐋇 ¦th an ks¦ ¦to¦ ¦vaccination¦ :
¦s ma ll po x¦ ¦is¦ ¦now¦ ¦e rad ic ated¦ ¦worldwide¦ ;
¦transmission¦ ¦of¦ ¦po li o¦ ¦has¦ ¦e nded¦ ¦in¦ ¦most¦ ¦par ts¦ ¦of¦ ¦the¦ ¦world¦ ,▁ ¦including¦ 𐋇 ¦europe¦ .
𐋇 ¦vaccination¦ ¦also¦ ¦preven ts¦ ¦the¦ ¦development¦ ¦of¦ ¦certain¦ ¦types¦ ¦of¦ ¦pre¦ - ¦cance r ous¦ ¦gr ow ths¦ ¦and¦ ¦ca nc ers¦ ,▁ ¦for¦ ¦example¦ :
¦vaccin ating¦ ¦against¦ ¦h um an p ap il lo ma¦ ¦virus¦ ▁(  )▁ ¦can¦ ¦help¦ ¦prevent¦ ¦c erv ical¦ ¦and¦ ¦other¦ ¦ca nc ers¦ ¦caused¦ ¦by¦  ¦infection¦ ;
¦vaccin ating¦ ¦against¦ ¦he p at itis¦ 𐋇 ¦b¦ ¦can¦ ¦help¦ ¦prevent¦ ¦li ver¦ ¦cancer¦ ¦caused¦ ¦by¦ ¦long¦ - ¦term¦ ¦he p at itis¦ 𐋇 ¦b¦ ¦infection¦ .
𐋇 ¦vaccination¦ ¦programmes¦ ¦have¦ ¦wi der¦ ¦soci et al¦ ¦be ne f its¦ .
𐋇 ¦vaccination¦ ¦is¦ ¦the¦ ¦best¦ ¦way¦ ¦to¦ ¦ac qu ire¦ ¦immunity¦ ¦against¦ ¦vaccine¦ - ¦preven t able¦ ¦diseases¦ ,▁ ¦as¦ ¦opp osed¦ ¦to¦ ¦immunity¦ ¦ at tained¦ ¦by¦ ¦getting¦ ¦the¦ ¦disease¦ .
𐋇 ¦vaccination¦ ¦prot ects¦ ¦the¦ ¦vaccinated¦ ¦persons¦ ¦and¦ ¦those¦ ¦around¦ ¦them¦ ¦who¦ ¦are¦ ¦vulnerable¦ ¦to¦ ¦the¦ ¦diseases¦ ,▁ ¦reduc ing¦ ¦the¦ ¦risk¦ ¦of¦ ¦diseases¦ ¦spreading¦ ¦among¦ ¦family¦ ¦members¦ ,▁ ¦school¦ ¦m ates¦ ¦or¦ ¦coll eag ues¦ ,▁ ¦fri ends¦ ,▁ ¦ne i gh b our s¦ ¦and¦ ¦other¦ ¦people¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦when¦ ¦enough¦ ¦people¦ ¦in¦ ¦a¦ ¦population¦ ¦are¦ ¦immune¦ ¦to¦ ¦an¦ ¦infectious¦ ¦disease¦ ,▁ ¦the¦ ¦disease¦ ¦is¦ ¦then¦ ¦un li k ely¦ ¦to¦ ¦spread¦ ¦from¦ ¦person¦ ¦to¦ ¦person¦ .
𐋇 ¦community¦ ¦immunity¦
𐋇 ¦community¦ ¦immunity¦ ¦occur s¦ ¦when¦ ¦enough¦ ¦people¦ ¦in¦ ¦a¦ ¦population¦ ¦are¦ ¦immune¦ ¦to¦ ¦an¦ ¦infectious¦ ¦disease¦
𐋇¦in¦ ¦this¦ ¦way¦ ,▁ ¦vaccines¦ ¦ind ir ect ly¦ ¦protect¦ ¦others¦ ¦who¦ ¦are¦ ¦vulnerable¦ ¦to¦ ¦disease¦ .
𐋇¦it¦ ¦means¦ ¦that¦ ¦people¦ ¦who¦ ¦cannot¦ ¦be¦ ¦vaccinated¦ ,▁ ¦for¦ ¦inst ance¦ ¦because¦ ¦they¦ ¦are¦ ¦too¦ ¦young¦ ¦or¦ ¦all er g ic¦ ¦to¦ ¦vaccine¦ ¦comp on ents¦ ,▁ ¦be ne f it¦ ¦from¦ ¦others¦ ¦being¦ ¦vaccinated¦ ,▁ ¦because¦ ¦the¦ ¦disease¦ ¦cannot¦ ¦eas i ly¦ ¦spread¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦to¦ ¦ensure¦ ¦community¦ ¦immunity¦ ¦against¦ ¦meas les¦ ,▁ ¦public¦ ¦health¦ ¦authorities¦ ¦recommend¦ ¦that¦ ¦95¦ %▁ ¦of¦ ¦the¦ ¦population¦ ¦are¦ ¦vaccinated¦ ¦with¦ ¦two¦ ¦doses¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦against¦ ¦meas les¦ ▁( ¦the¦  ¦vaccine¦ ,▁ ¦which¦ ¦prot ects¦ ¦against¦ ¦meas les¦ ,▁ ¦m um ps¦ ¦and¦ ¦r ub e ll a¦ ).
𐋇¦however¦ ,▁ ¦people¦ ¦cannot¦ ¦r ely¦ ¦on¦ ¦community¦ ¦immunity¦ ¦for¦ ¦some¦ ¦infectious¦ ¦diseases¦ .
𐋇¦f ur th erm ore¦ ,▁ ¦immun isation¦ ¦programmes¦ ¦help¦ ¦reduce¦ ¦the¦ ¦social¦ ,▁ ¦ps ych ological¦ ¦and¦ ¦fi na ncial¦ ¦b ur d ens¦ ¦of¦ ¦disease¦ ¦on¦ ¦people¦ ¦and¦ ¦governments¦ ,▁ ¦reduc ing¦ ¦p ress ur es¦ ¦on¦ ¦healthcare¦ ¦and¦ ¦social¦ ¦care¦ ¦systems¦ ¦and¦ ¦en ab ling¦ ¦people¦ ¦to¦ ¦pu rs ue¦ ¦produc tive¦ ¦activities¦ ¦including¦ ¦education¦ ¦and¦ ¦employ ment¦ .
𐋇 ¦vaccination¦ ¦prot ects¦ ¦individuals¦ ¦against¦ ¦diseases¦ ¦that¦ ¦could¦ ¦have¦ ¦serious¦ ¦con se qu ences¦ ¦for¦ ¦their¦ ¦health¦ ,▁ ¦for¦ ¦example¦ :
¦di ph ther ia¦ ¦ki lls¦ ¦1¦ ¦in¦ ¦every¦ ¦10¦ ¦people¦ ¦who¦ ¦get¦ ¦it¦ ,▁ ¦even¦ ¦with¦ ¦treatment¦ ▁( ¦1¦ ) ;
¦almost¦ ¦9¦ ¦out¦ ¦of¦ ¦10¦ ¦b ab ies¦ ¦bor n¦ ¦to¦ ¦mo th ers¦ ¦who¦ ¦had¦ ¦r ub e ll a¦ ¦in¦ ¦early¦ ¦pregnancy¦ ,▁ ¦will¦ ¦suff er¦ ¦from¦ ¦co ng en it al¦ ¦r ub e ll a¦ ¦syndrome¦ ▁( ¦with¦ ¦conditions¦ ¦such¦ ¦as¦ ¦d ea f ness¦ ,▁ ¦cat ar ac ts¦ ¦and¦ ¦learning¦ ¦dis ab ilities¦ ) ▁( ¦2¦ ) ;
¦me ni ng oc oc c al¦ ¦disease¦ ¦ki lls¦ ¦1¦ ¦in¦ ¦10¦ ¦people¦ ¦affected¦ ,▁ ¦even¦ ¦with¦ ¦promp t¦ ¦diagnosis¦ ¦and¦ ¦treatment¦ ,▁ ¦while¦ ¦problems¦ ¦including¦ ¦ne ur ological¦ ¦or¦ ¦hea ring¦ ¦imp a ir ment¦ ¦and¦ ¦a mp ut ation¦ ¦occur¦ ¦in¦ ¦up¦ ¦to¦ ¦20¦ %▁ ¦of¦ ¦sur v iv ors¦ ▁( ¦3¦ ) ;▁
¦meas les¦ ¦is¦ ¦highly¦ ¦contag ious¦ ¦and¦ ¦3¦ ¦out¦ ¦of¦ ¦10¦ ¦people¦ ¦affected¦ ¦develop¦ ¦complications¦ ▁( ¦4¦ ),▁ ¦which¦ ¦can¦ ¦include¦ ¦ ear¦ ¦infection¦ ,▁ ¦di ar r ho e a¦ ,▁ ¦pneumonia¦ ¦and¦ ¦en ce ph al itis¦ ▁( ¦inf la m mation¦ ¦of¦ ¦the¦ ¦b ra in¦ ¦tissue¦ ) ;
¦pe rt us sis¦ ▁( ¦wh oo ping¦ ¦cough¦ )▁ ¦can¦ ¦be¦ ¦particularly¦ ¦serious¦ ¦in¦ ¦in fa nts¦ ,▁ ¦causing¦ ¦coughing¦ ¦sp e lls¦ ¦that¦ ¦may¦ ¦re cu r¦ ¦for¦ ¦up¦ ¦to¦ ¦two¦ ¦months¦ .
𐋇¦this¦ ¦list¦ ¦with¦ ¦exa mp les¦ ¦includes¦ ¦diseases¦ ¦for¦ ¦which¦ ¦vaccines¦ ¦are¦ ¦included¦ ¦in¦ ¦the¦ ¦national¦ ¦immun isation¦ ¦programmes¦ ,▁ ¦and¦ / ¦or¦ ¦are¦ ¦given¦ ¦to¦ ¦persons¦ ¦considered¦ ¦to¦ ¦be¦ ¦at¦ ¦a¦ ¦higher¦ ¦risk¦ ¦of¦ ¦getting¦ ¦the¦ ¦disease¦ .
𐋇¦vaccines¦ ¦protect¦ ¦people¦ ¦during¦ ¦different¦ ¦stages¦ ¦of¦ ¦life¦ .
𐋇 ¦national¦ ¦vaccination¦ ¦schedu les¦ ¦in¦  /  ¦countries¦ ¦recommend¦ ¦vaccines¦ ¦at¦ ¦specific¦ ¦ ages¦ ¦and¦ ¦for¦ ¦specific¦ ¦p op ul ations¦ .
𐋇 ¦healthcare¦ ¦prof es sion als¦
𐋇¦some¦ ¦vaccines¦ ¦are¦ ¦not¦ ¦part¦ ¦of¦ ¦routine¦ ¦vaccination¦ ¦schedu les¦ ¦but¦ ¦are¦ ¦t ar ge ted¦ ¦at¦ ¦specific¦ ¦groups¦ .
𐋇 ¦each¦  /  ¦country¦ ¦is¦ ¦respon sible¦ ¦for¦ ¦its¦ ¦own¦ ¦national¦ ¦public¦ ¦health¦ ¦policy¦ ,▁ ¦including¦ ¦its¦ ¦national¦ ¦immun isation¦ ¦programme¦ ¦and¦ ¦vaccination¦ ¦schedu le¦ .▁ 𐋇 ¦information¦ ¦on¦ ¦the¦ ¦national¦ ¦vaccination¦ ¦schedu les¦ ¦in¦  /  ¦countries¦ ¦can¦ ¦be¦ ¦found¦ ¦in¦ ¦the¦  𐋇 ¦vaccine¦ 𐋇 ¦schedu l er¦
𐋇¦there¦ ¦are¦ ¦some¦ ¦diff er ences¦ ¦in¦ ¦the¦ ¦way¦ ¦countries¦ ¦organ ise¦ ¦their¦ ¦vaccination¦ ¦schedu les¦ ,▁ ¦which¦ ¦are¦ ¦similar¦ ¦but¦ ¦not¦ ¦ident ical¦ ¦in¦ ¦different¦  /  ¦countries¦ .
𐋇 ¦factors¦ ¦dr iving¦ ¦such¦ ¦diff er ences¦ ¦may¦ ¦include¦ ¦the¦ ¦disease¦ ' ¦s¦ ¦b ur den¦ ,▁ ¦prevalence¦ ¦of¦ ¦the¦ ¦disease¦ ¦and¦ ¦trends¦ ¦in¦ ¦different¦ ¦countries¦ ,▁ ¦the¦ ¦resources¦ ¦and¦ ¦st ruct ur es¦ ¦of¦ ¦healthcare¦ ¦systems¦ ,▁ ¦political¦ ¦and¦ ¦cultural¦ ¦factors¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦re si li ence¦ ¦of¦ ¦the¦ ¦vaccination¦ ¦programme¦ .
𐋇¦the¦ ¦diff er ences¦ ¦between¦ ¦vaccination¦ ¦schedu les¦ ¦do¦ ¦not¦ ¦me an¦ ¦that¦ ¦some¦ ¦are¦ ¦better¦ ¦than¦ ¦others¦ .
𐋇¦the¦ ¦ch ild h ood¦ ¦vaccination¦ ¦schedu les¦ ¦in¦ ¦all¦  /  ¦countries¦ ¦include¦ ¦the¦ ¦vaccination¦ ¦against¦ :
¦meas les¦
¦m um ps¦
¦r ub e ll a¦
¦di ph ther ia¦
¦t et an us¦
¦pe rt us sis¦ ▁( ¦wh oo ping¦ ¦cough¦ )
¦po li om y el itis¦
𐋇 ¦ha e mo ph il us¦ ¦inf lu en z a e¦ ¦type¦ 𐋇 ¦b¦
¦human¦ ¦p ap il lo ma virus¦ ▁( ¦ad ol es cent¦ / ¦pre¦ - ¦ad ol es cent¦ ¦g ir l s¦ ).
𐋇¦the¦ 𐋇 ¦world¦ 𐋇¦health¦ 𐋇 ¦organization¦ ▁(  )▁ ¦recommends¦ ¦vaccination¦ ¦against¦ ¦he p at itis¦ 𐋇 ¦b¦ ¦as¦ ¦part¦ ¦of¦ ¦the¦ ¦uni vers al¦ ¦ch ild h ood¦ ¦vaccination¦ ¦schedu le¦ ,▁ ¦but¦ ¦some¦  /  ¦countries¦ ¦only¦ ¦vaccin ate¦ ¦children¦ ¦at¦ ¦high¦ ¦risk¦ ¦of¦ ¦infection¦ ¦and¦ ¦adults¦ ¦in¦ ¦key¦ ¦risk¦ ¦groups¦ .
𐋇¦children¦ ¦in¦ ¦some¦  /  ¦countries¦ ¦are¦ ¦off ered¦ ¦protection¦ ¦through¦ ¦vaccination¦ ¦against¦ :
¦he p at itis¦ 𐋇¦a¦
¦influenza¦
¦inv as ive¦ ¦disease¦ ¦caused¦ ¦by¦ 𐋇¦ne i ss er ia¦ ¦me ni ng i ti di s¦
¦inv as ive¦ ¦disease¦ ¦caused¦ ¦by¦ 𐋇¦st re pt oc oc c us¦ ¦p ne u mon ia e¦
¦ro ta virus¦
¦t ub er cu lo sis¦
¦vari ce ll a¦
𐋇¦in¦ ¦addition¦ ,▁ ¦all¦  /  ¦countries¦ ¦have¦ ¦recommend ations¦ ¦for¦ ¦se as onal¦ ¦influenza¦ ▁( ¦flu¦ )▁ ¦for¦ ¦older¦ ¦people¦ ¦and¦ ¦key¦ ¦risk¦ ¦groups¦ .
𐋇¦the¦  ¦is¦ ¦exp lo ring¦ ¦further¦ ¦har mon isation¦ ¦of¦ ¦national¦ ¦vaccination¦ ¦schedu les¦ .▁ 𐋇¦the¦  𐋇 ¦cou nc il¦ ¦issued¦ 𐋇 ¦recommend ations¦ ¦on¦ ¦7¦ 𐋇 ¦december¦ ¦20 18¦
¦on¦ ¦strength ened¦ ¦co op er ation¦ ¦against¦ ¦vaccine¦ - ¦preven t able¦ ¦diseases¦ ,▁ ¦which¦ ¦include¦ ¦exa mi ning¦ ¦the¦ ¦f ea sibility¦ ¦of¦ ¦a¦ ¦c ore¦  ¦vaccination¦ ¦schedu le¦ .
𐋇¦the¦ ¦ai m¦ ¦would¦ ¦be¦ ¦to¦ ¦improve¦ ¦the¦ ¦com pa ti bility¦ ¦of¦ ¦national¦ ¦vaccination¦ ¦schedu les¦ ¦and¦ ¦pr om ot e¦ ¦e q ual¦ ¦access¦ ¦to¦ ¦vaccin ations¦ ¦across¦ ¦the¦  .
𐋇 ¦each¦  /  ¦country¦ ¦imple ments¦ ¦its¦ ¦own¦ ¦immun isation¦ ¦programme¦ .
 /  ¦countries¦ ¦have¦ ¦a ch ie ved¦ ¦high¦ ¦vaccination¦ ¦co verage¦ ¦rates¦ ¦through¦ ¦mandatory¦ ¦and¦ ¦non¦ - ¦mandatory¦ ¦vaccination¦ .
𐋇 ¦each¦  /  ¦country¦ ¦deci des¦ ¦if¦ ¦vaccination¦ ¦is¦ ¦mandatory¦ ¦or¦ ¦volu nt ary¦ ¦in¦ ¦its¦ ¦territ ory¦ .
𐋇 ¦information¦ ¦on¦ ¦which¦ ¦countries¦ ¦have¦ ¦mandatory¦ ¦vaccination¦ ¦can¦ ¦be¦ ¦found¦ ¦in¦ ¦the¦ 𐋇 ¦vaccine¦ 𐋇 ¦schedu l er¦ .
𐋇¦some¦ ¦people¦ ¦may¦ ¦have¦ ¦mis sed¦ ¦a¦ ¦vaccination¦ ¦or¦ ¦did¦ ¦not¦ ¦get¦ ¦the¦ ¦recommended¦ ¦number¦ ¦of¦ ¦doses¦ .
𐋇¦everyone¦ ¦should¦ ¦check¦ ¦if¦ ¦they¦ ¦have¦ ¦had¦ ¦the¦ ¦na tion ally¦ ¦recommended¦ ¦vaccin ations¦ ,▁ ¦and¦ ¦cons ul t¦ ¦a¦ ¦medical¦ ¦prof es si onal¦ ¦in¦ ¦case¦ ¦any¦ ¦cat ch¦ - ¦u ps¦ ¦are¦ ¦needed¦ .
𐋇¦if¦ ¦a¦ ¦person¦ ¦does¦ ¦not¦ ¦know¦ ¦if¦ ¦they¦ ¦have¦ ¦been¦ ¦vaccinated¦ ¦against¦ ¦a¦ ¦certain¦ ¦disease¦ ¦they¦ ¦can¦ ¦usually¦ ¦get¦ ¦an¦ ¦extra¦ ¦dose¦ ¦without¦ ¦increasing¦ ¦the¦ ¦risk¦ ¦of¦ ¦serious¦ ¦side¦ ¦effects¦ ▁( ¦1¦ ).
¦meas les¦ ¦vaccine¦
 ¦i 𐋇 st ock¦
𐋇 ¦cat ch¦ - ¦up¦ ¦vaccination¦ ¦programmes¦ ¦for¦ ¦specific¦ ¦diseases¦ ¦may¦ ¦be¦ ¦organ i sed¦ .
𐋇¦most¦ ¦vaccines¦ ¦provide¦ ¦li fe long¦ ¦immunity¦ .
𐋇¦however¦ ,▁ ¦some¦ ¦vaccines¦ ¦provide¦ ¦immunity¦ ¦that¦ ¦dec reases¦ ¦over¦ ¦time¦ ,▁ ¦known¦ ¦as¦ ▁ ‘ ¦wa ning¦ ¦immunity¦ ’ .▁ 𐋇¦some¦ ¦countries¦ ¦recommend¦ ¦bo os ter¦ ¦doses¦ ¦at¦ ¦regular¦ ¦int erv als¦ ¦during¦ ¦ad ol es c ence¦ ¦and¦ ¦ad ul th ood¦ ,▁ ¦in¦ ¦order¦ ¦to¦ ¦main tain¦ ¦immunity¦ ¦over¦ ¦a¦ ¦longer¦ ¦period¦ ¦of¦ ¦time¦ ,▁ ¦against¦ ¦for¦ ¦example¦ :
¦di ph ther ia¦
¦t et an us¦
¦pe rt us sis¦ ▁( ¦wh oo ping¦ ¦cough¦ )
𐋇¦some¦ ¦countries¦ ¦recommend¦ ¦b oo st ers¦ ¦spec if ically¦ ¦for¦ ¦individuals¦ ¦trave lling¦ ¦or¦ ¦at¦ ¦increased¦ ¦risk¦ ¦of¦ ¦being¦ ¦exposed¦ ¦to¦ ¦the¦ ¦disease¦ .▁
𐋇 ¦healthcare¦ ¦provi ders¦ ¦can¦ ¦provide¦ ¦information¦ ¦on¦ ¦the¦ ¦bo os ter¦ ¦doses¦ ¦needed¦ .
𐋇¦a¦ ¦vaccine¦ ¦may¦ ¦be¦ ¦contr ai nd ic ated¦ ¦for¦ ¦certain¦ ¦people¦ ,▁ ¦mea ning¦ ¦they¦ ¦should¦ ¦not¦ ¦receive¦ ¦it¦ .
𐋇¦a¦ ¦vaccine¦ ¦is¦ ¦contr ai nd ic ated¦ ¦to¦ ¦those¦ ¦all er g ic¦ ¦to¦ ¦any¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦active¦ ¦sub st ances¦ ¦or¦ ¦in gre di ents¦ ¦as¦ ¦l is ted¦ ¦in¦ ¦the¦ ¦produc t¦ ¦information¦ .
𐋇¦a¦ ¦history¦ ¦of¦ ▁' ¦a na ph y la ct ic¦ '▁ ¦or¦ ¦other¦ ¦serious¦ ¦all er g ic¦ ¦reaction¦ ¦after¦ ¦receiving¦ ¦a¦ ¦vaccine¦ ¦is¦ ¦a¦ ¦contr ai nd ication¦ ¦to¦ ¦further¦ ¦doses¦ ¦of¦ ¦that¦ ¦vaccine¦ .
𐋇 ¦certain¦ ¦immune¦ ¦system¦ ¦dis or ders¦ ▁( ¦e¦ .
𐋇¦in¦ ¦some¦ ¦cases¦ ,▁ ¦the¦ ¦comple tion¦ ¦of¦ ¦the¦ ¦immun is ations¦ ¦needed¦ ¦is¦ ¦recommended¦ ¦prior¦ ¦to¦ ¦the¦ ¦start¦ ¦of¦ ¦a¦ ¦treatment¦ ,▁ ¦as¦ ¦during¦ ¦the¦ ¦treatment¦ ¦the¦ ¦patient¦ ¦may¦ ¦be¦ ¦at¦ ¦higher¦ ¦r is ks¦ ¦of¦ ¦infection¦ .
𐋇¦some¦ ¦vaccines¦ ¦are¦ ¦contr ai nd ic ated¦ ¦during¦ ¦pregnancy¦ ,▁ ¦such¦ ¦as¦ ¦meas les¦ ,▁ ¦m um ps¦ ¦and¦ ¦r ub e ll a¦ .
𐋇¦there¦ ¦may¦ ¦be¦ ¦other¦ ¦contr ai nd ications¦ ¦for¦ ¦specific¦ ¦vaccines¦ ,▁ ¦which¦ ¦need¦ ¦dis cu ssing¦ ¦with¦ ¦the¦ ¦healthcare¦ ¦provider¦ .
𐋇¦vaccines¦ ¦are¦ ¦used¦ ¦worldwide¦ ¦as¦ ¦a¦ ¦highly¦ ¦effective¦ ¦way¦ ¦to¦ ¦protect¦ ¦people¦ ¦from¦ ¦contr acting¦ ¦infectious¦ ¦diseases¦ .
𐋇¦the¦ ¦first¦ ¦vaccine¦ ¦was¦ ¦developed¦ ¦in¦ ¦the¦ ¦18 th¦ ¦ cent u ry¦ ¦in¦ ¦the¦ 𐋇 ¦united¦ 𐋇 ¦kingdom¦ .
𐋇¦n ow a d ays¦ ,▁ ¦there¦ ¦are¦ ¦vaccines¦ ¦for¦ ¦many¦ ¦diseases¦ .
𐋇¦this¦ ¦video¦ ¦is¦ ¦available¦ ¦in¦ ¦24¦  ¦la ng u ages¦ .
𐋇 ¦safety¦ ,▁ ¦qu ality¦ ¦and¦ ¦stand ards¦
𐋇¦before¦ ¦any¦ ¦new¦ ¦vaccine¦ ¦can¦ ¦be¦ ¦used¦ ,▁ ¦it¦ ¦has¦ ¦to¦ ¦under g o¦ ¦r ig or ous¦ ¦testing¦ .
𐋇¦this¦ ¦e va lu ation¦ ¦needs¦ ¦to¦ ¦show¦ ¦that¦ ¦a¦ ¦vaccine¦ ’ ¦s¦ ¦be ne f its¦ ¦in¦ ¦protecting¦ ¦people¦ ¦against¦ ¦diseases¦ ¦are¦ ¦far¦ ¦greater¦ ¦than¦ ¦any¦ ¦potential¦ ¦risk¦ .
𐋇¦only¦ ¦then¦ ,▁ ¦after¦ ¦approval¦ ,▁ ¦can¦ ¦a¦ ¦vaccine¦ ¦be¦ ¦manufact ured¦ ,▁ ¦mar ke ted¦ ¦and¦ ¦used¦ ¦to¦ ¦protect¦ ¦people¦ .
𐋇¦as¦ ¦with¦ ¦any¦ ¦medic ine¦ ,▁ ¦some¦ ¦people¦ ¦may¦ ¦experience¦ ¦side¦ ¦effects¦ ¦from¦ ¦a¦ ¦vaccine¦ ,▁ ¦but¦ ¦these¦ ¦are¦ ¦usually¦ ¦mild¦ ¦and¦ ¦short¦ - ¦li ved¦ .
𐋇¦be ne f its¦ ¦of¦ ¦vaccin ating¦
𐋇¦vaccines¦ ¦prevent¦ ¦diseases¦ ¦that¦ ¦could¦ ¦o ther w ise¦ ¦cause¦ ¦serious¦ ¦health¦ ¦problems¦ ,▁ ¦perm an ent¦ ¦disability¦ ¦or¦ ¦even¦ ¦death¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦during¦ ¦20 18¦ ¦about¦ ¦8 6¦ %▁ ¦of¦ ¦in fa nts¦ ¦worldwide¦ ¦received¦ ¦three¦ ¦doses¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦that¦ ¦prot ects¦ ¦them¦ ¦against¦ ¦di ph ther ia¦ ,▁ ¦t et an us¦ ¦and¦ ¦pe rt us sis¦ ▁(  ),▁ ¦and¦ ¦8 5¦ %▁ ¦of¦ ¦in fa nts¦ ¦around¦ ¦the¦ ¦world¦ ¦received¦ ¦three¦ ¦doses¦ ¦of¦ ¦po li o¦ ¦vaccine¦ ▁( ¦1¦ ).
𐋇 ¦un li ke¦ ¦a¦ ¦treatment¦ ¦given¦ ¦to¦ ¦c ure¦ ¦an¦ ¦illness¦ ,▁ ¦vaccines¦ ¦are¦ ¦usually¦ ¦given¦ ¦to¦ ¦healthy¦ ¦people¦ ¦to¦ ¦prevent¦ ¦them¦ ¦from¦ ¦getting¦ ¦ill¦ .
𐋇¦many¦ ¦infectious¦ ¦diseases¦ ¦are¦ ¦very¦ ¦r are¦ ¦today¦ ¦th an ks¦ ¦to¦ ¦vaccination¦ ,▁ ¦so¦ ¦the¦ ¦negative¦ ¦con se qu ences¦ ¦of¦ ¦these¦ ¦diseases¦ ¦are¦ ¦sometimes¦ ¦for g ot t en¦ .
𐋇 ¦example¦ :▁ ¦meas les¦
𐋇 ¦meas les¦ ¦had¦ ¦almost¦ ¦been¦ ¦e li minated¦ ¦in¦ ¦many¦ 𐋇 ¦european¦ ¦countries¦ .
𐋇¦however¦ ,▁ ¦since¦ 𐋇 ¦o ct ob er¦ ¦201 6¦ ¦a¦ ¦res ur gence¦ ¦of¦ ¦meas les¦ ¦has¦ ¦been¦ ¦observed¦ ¦in¦ ¦the¦  /  ,▁ ¦with¦ ¦outbreaks¦ ¦in¦ ¦several¦ ¦countries¦ ▁( ¦2¦ ),▁ ¦due¦ ¦to¦ ¦a¦ ¦dec line¦ ¦in¦ ¦vaccination¦ ¦rates¦ .
𐋇 ¦meas les¦ ¦can¦ ¦be¦ ¦serious¦ ¦or¦ ¦even¦ ¦life¦ - ¦thre at ening¦ .
𐋇¦the¦ ¦only¦ ¦protection¦ ¦against¦ ¦meas les¦ ¦is¦ ¦vaccination¦ .
𐋇 ¦example¦ :▁ ¦pe rt us sis¦
𐋇 ¦pe rt us sis¦ ▁( ¦wh oo ping¦ ¦cough¦ )▁ ¦is¦ ¦a¦ ¦disease¦ ¦affecting¦ ¦the¦ ¦air w ays¦ .
𐋇 ¦complications¦ ¦can¦ ¦include¦ ¦pneumonia¦ ,▁ ¦en cep ha lo pa thy¦ ▁( ¦a¦ ¦disease¦ ¦of¦ ¦the¦ ¦b ra in¦ ),▁ ¦se iz ur es¦ ¦and¦ ¦even¦ ¦death¦ .
𐋇 ¦vaccination¦ ¦against¦ ¦pe rt us sis¦ ¦is¦ ¦part¦ ¦of¦ ¦national¦ ¦immun isation¦ ¦programmes¦ ¦in¦ ¦the¦  .
𐋇 ¦approval¦ ¦of¦ ¦vaccines¦ ¦in¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦union¦
𐋇¦before¦ ¦a¦ ¦vaccine¦ ¦can¦ ¦be¦ ¦approved¦ ¦in¦ ¦the¦  ,▁ ¦it¦ ¦has¦ ¦to¦ ¦under g o¦ ¦r ig or ous¦ ¦testing¦ ¦by¦ ¦its¦ ¦de v el op er¦ ¦and¦ ¦then¦ ¦scientific¦ ¦e va lu ation¦ ¦by¦ ¦reg ul atory¦ ¦authorities¦ .
𐋇 ¦testing¦ ¦includes¦ ¦chec king¦ ¦the¦ ¦vaccine¦ ’ ¦s¦ ¦qu ality¦ :
¦its¦ ¦p urity¦ ;
¦its¦ ¦in gre di ents¦ ,▁ ¦including¦ ¦its¦ ¦in ac tive¦ ¦in gre di ents¦ ¦or¦ ▁ ‘ ¦exc ip i ents¦ ’ ;
¦how¦ ¦it¦ ¦is¦ ¦manufact ured¦ .
𐋇 ¦then¦ ¦the¦ ¦vaccine¦ ¦de v el op er¦ ¦tests¦ ¦the¦ ¦vaccine¦ ’ ¦s¦ ¦effects¦ .
𐋇¦this¦ ¦is¦ ¦followed¦ ¦by¦ ¦a¦ ¦clinical¦ ¦testing¦ ¦programme¦ ¦in¦ ¦humans¦ .
𐋇¦this¦ ¦can¦ ¦take¦ ¦around¦ ¦ten¦ ¦years¦ ¦from¦ ¦initial¦ ¦con cep t¦ ¦to¦ ¦au th or isation¦ .
¦20¦ ▁-▁ ¦100¦ ¦healthy¦ ¦volu n te ers¦
𐋇¦what¦ ¦is¦ ¦chec ked¦ :▁
𐋇 ¦does¦ ¦the¦ ¦vaccine¦ ¦see m¦ ¦to¦ ¦work¦ ?
𐋇 ¦are¦ ¦there¦ ¦serious¦ ¦side¦ ¦effects¦ ?
𐋇 ¦is¦ ¦the¦ ¦vaccine¦ ¦safe¦ ?
𐋇¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦the¦ ¦testing¦ ¦programme¦ ,▁ ¦the¦ ¦vaccine¦ ¦de v el op er¦ ¦sub m its¦ ¦the¦ ¦results¦ ¦to¦ ¦the¦ ¦medicines¦ ¦reg ul atory¦ ¦authorities¦ ¦in¦ 𐋇 ¦europe¦ ¦as¦ ¦part¦ ¦of¦ ¦a¦ ▁ ‘ ¦mar ke ting¦ ¦au th or isation¦ ’ ▁ ¦appl ication¦ .
𐋇¦the¦ ¦reg ul ators¦ ¦can¦ ¦only¦ ¦app ro ve¦ ¦the¦ ¦vaccine¦ ¦if¦ ¦its¦ ¦scientific¦ ¦e va lu ation¦ ¦of¦ ¦the¦ ¦tests¦ ¦results¦ ¦show¦ ¦that¦ ¦the¦ ¦vaccine¦ ’ ¦s¦ ¦be ne f its¦ ¦are¦ ¦greater¦ ¦than¦ ¦its¦ ¦r is ks¦ .
𐋇 ¦medicines¦ ¦reg ul atory¦ ¦authorities¦ ¦can¦ ¦car ry¦ ¦out¦ ¦in sp ections¦ ¦to¦ ¦make¦ ¦sure¦ ¦that¦ ¦the¦ ¦information¦ ¦the¦ ¦vaccine¦ ¦de v el op er¦ ¦provides¦ ¦is¦ ¦tr ust wor thy¦ .
𐋇 ¦monitoring¦ ¦vaccine¦ ¦safety¦ ¦and¦ ¦reporting¦ ¦side¦ ¦effects¦
𐋇 ¦once¦ ¦a¦ ¦vaccine¦ ¦is¦ ¦approved¦ ¦for¦ ¦use¦ ,▁  /  ¦national¦ ¦authorities¦ ¦and¦ ¦the¦ 𐋇 ¦european¦ 𐋇 ¦medicines¦ 𐋇 ¦agency¦
(  ),▁ ¦continu ally¦ ¦monitor¦ ¦side¦ ¦effects¦ ¦in¦ ¦people¦ ¦who¦ ¦have¦ ¦received¦ ¦the¦ ¦vaccine¦ .
𐋇¦this¦ ¦ ens ur es¦ ¦that¦ ¦any¦ ¦possible¦ ¦r is ks¦ ¦are¦ ¦detected¦ ¦and¦ ¦mana ged¦ ¦as¦ ¦soon¦ ¦as¦ ¦possible¦ .
 ¦chec ks¦ ¦new¦ ¦information¦ ¦on¦ ¦the¦ ¦safety¦ ¦of¦ ¦all¦ ¦vaccines¦ ¦available¦ ¦in¦ 𐋇 ¦europe¦ .▁ 𐋇¦it¦ ¦an al y ses¦ ¦many¦ ¦s ources¦ ¦of¦ ¦data¦ ,▁ ¦including¦ :
¦reports¦ ¦from¦ ¦patients¦ ,▁ ¦parents¦ ¦and¦ ¦healthcare¦ ¦prof es sion als¦ ;
¦clinical¦ ¦studies¦ ;
¦the¦ ¦medical¦ ¦li ter at ure¦ ;
¦information¦ ¦shared¦ ¦by¦ ¦other¦ ¦reg ul ators¦ .
 ¦care fully¦ ¦ass es ses¦ ¦suspected¦ ¦side¦ ¦effects¦ ¦to¦ ¦determine¦ ¦if¦ ¦there¦ ¦is¦ ¦a¦ ¦ca us al¦ ¦link¦ ¦with¦ ¦the¦ ¦vaccine¦ ¦or¦ ¦not¦ .
𐋇¦this¦ ¦video¦ ¦is¦ ¦available¦ ¦in¦ ¦24¦  ¦la ng u ages¦ .
𐋇¦when¦ ¦needed¦ ,▁  ¦and¦ ¦the¦ ¦other¦ 𐋇 ¦european¦ ¦reg ul ators¦ ¦take¦ ¦a ction¦ .
𐋇¦patients¦ ,▁ ¦healthcare¦ ¦prof es sion als¦ ¦and¦ ¦pharm a ce ut ical¦ ¦compan ies¦ ¦should¦ ¦report¦ ¦all¦ ¦suspected¦ ¦side¦ ¦effects¦ ¦to¦ ¦their¦ ¦national¦ ¦medicines¦ ¦reg ul atory¦ ¦authority¦ .
𐋇 ¦information¦ ¦on¦ ¦these¦ ¦reported¦ ¦suspected¦ ¦side¦ ¦effects¦ ¦is¦ ¦publ ic ly¦ ¦available¦ ¦on¦ ¦the¦ 𐋇 ¦european¦ ¦d at ab ase¦ ¦of¦ ¦suspected¦ ¦ad verse¦ ¦drug¦ ¦reaction¦ ¦reports¦ .▁
𐋇¦the¦ ¦process¦ ¦of¦ ¦monitoring¦ ¦the¦ ¦safety¦ ¦and¦ ¦mana ging¦ ¦the¦ ¦r is ks¦ ¦of¦ ¦medicines¦ ¦is¦ ¦called¦ ▁ ‘ ¦pharm ac ov ig il ance¦ ’ .
𐋇 ¦vaccine¦ ¦effectiveness¦
𐋇¦a¦ ¦vaccine¦ ' ¦s¦ ¦ability¦ ¦to¦ ¦prevent¦ ¦a¦ ¦specific¦ ¦disease¦ ¦determ ines¦ ¦its¦ ¦effectiveness¦ .
𐋇¦as¦ ¦with¦ ¦any¦ ¦medic ine¦ ,▁ ¦no¦ ¦vaccine¦ ¦is¦ ¦100¦ %▁ ¦effective¦ ¦in¦ ¦every¦ ¦person¦ ¦vaccinated¦ .
𐋇¦these¦ ¦include¦ :
